https://curecurrent.com/trials/study-of-cxcr5-modified-egfe-chimeric-antigen-receptor-autologous-t-cells-in-egfr-positive-patients-with-advanced-non-sm-50001https://curecurrent.com/trials/dna-repair-p53-and-apoptosis-phenotypes-in-lung-cancer-50002https://curecurrent.com/trials/avastin-docetaxel-carboplatin-in-non-small-cell-lung-cancer-50003https://curecurrent.com/trials/study-of-combined-ionizing-radiation-and-ipilimumab-in-metastatic-non-small-cell-lung-cancer-nsclc-50004https://curecurrent.com/trials/camrelizumab-combined-with-apatinib-mesylate-or-camrelizumab-alone-for-first-line-treatment-in-subjects-with-programmed-50005https://curecurrent.com/trials/study-to-describe-treatment-patterns-and-outcomes-in-egfrm-nsclc-patients-in-belgium-50006https://curecurrent.com/trials/safe-return-to-regular-clinical-operation-after-covid-19-pandemic-50007https://curecurrent.com/trials/serum-autoantibodies-in-predicting-the-efficacy-of-anti-pd-1-treatment-in-patients-with-advanced-nsclc-50008https://curecurrent.com/trials/a-phase-i-study-of-safety-tolerability-and-pk-of-azd2811-in-patients-with-advanced-solid-tumors-50009https://curecurrent.com/trials/effectiveness-of-a-preoperative-pulmonary-rehabilitation-program-in-patients-awaiting-lung-resection-50010https://curecurrent.com/trials/sintilimab-ibi308-in-the-neoadjuvant-treatment-of-patients-with-resectable-ii-iiia-nsclc-50011https://curecurrent.com/trials/outcomes-following-omission-of-daily-routine-chest-radiographs-following-pulmonary-resection-50012https://curecurrent.com/trials/superdimension-navigation-system-version-7-2-with-fluoroscopic-navigation-technology-50013https://curecurrent.com/trials/oncogeriatric-intervention-and-follow-up-at-home-50014https://curecurrent.com/trials/diflomotecan-bn80915-administered-once-every-3-weeks-in-treating-patients-with-sensitive-small-cell-lung-cancer-sclc-50015https://curecurrent.com/trials/assessing-the-pharmacokinetics-effects-of-food-on-ask120067-in-single-oral-administration-in-chinese-healthy-subjects-50016https://curecurrent.com/trials/first-line-chemotherapy-followed-by-toripalimab-combined-with-anlotinib-for-maintenance-in-es-sclc-50017https://curecurrent.com/trials/lifestyle-modification-program-for-lung-cancer-patients-a-pilot-study-50018https://curecurrent.com/trials/a-study-of-atezolizumab-as-first-line-monotherapy-for-advanced-or-metastatic-non-small-cell-lung-cancer-50019https://curecurrent.com/trials/study-of-epigallocatechin-3-gallate-egcg-for-esophagus-protection-in-patients-with-lung-cancer-receiving-radial-radiothe-50020https://curecurrent.com/trials/lifestyle-modification-program-for-lung-cancer-patients-physical-activity-preference-50021https://curecurrent.com/trials/bronchoscopic-microwave-intervention-treatment-in-advanced-central-nsclc-50022https://curecurrent.com/trials/incmga00012-plus-chemotherapy-in-participants-with-advanced-solid-tumors-pod1um-105-50023https://curecurrent.com/trials/nelfinavir-radiation-therapy-cisplatin-and-etoposide-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-that-50024https://curecurrent.com/trials/a-phase-i-study-of-safety-and-pharmacokinetics-of-volitinib-in-combination-with-gefitinib-in-egfr-nsclc-50025https://curecurrent.com/trials/gefitinib-with-anlotinib-in-advanced-non-squamous-nsclc-patients-with-uncleared-plasma-ctdna-egfrm-after-first-line-trea-50026https://curecurrent.com/trials/nitroglycerin-plus-intracranial-radiotherapy-for-brain-metastases-in-nsclc-patients-50027https://curecurrent.com/trials/advanced-lung-cancer-treatment-with-metformin-and-chemo-radiotherapy-50028https://curecurrent.com/trials/phase-i-study-of-a-statin-erlotinib-for-advanced-solid-malignancies-with-focus-on-squamous-cell-carcinomas-and-nsclc-50029https://curecurrent.com/trials/impact-of-inactivated-trivalent-influenza-vaccine-on-nsclc-patients-receiving-pd-1-pd-l1-inhibitors-50030https://curecurrent.com/trials/genetic-epidemiology-of-lung-cancer-50031https://curecurrent.com/trials/a-phase-1b-study-of-atezolizumab-in-combination-with-erlotinib-or-alectinib-in-participants-with-non-small-cell-lung-can-50032https://curecurrent.com/trials/a-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-oral-ceritinib-in-patients-with-alk-positive-nsclc-metastatic-to-50033https://curecurrent.com/trials/diagnosing-pulmonary-aspergillosis-in-patients-with-hematological-malignancies-a-multicentre-prospective-evaluation-of-a-50034https://curecurrent.com/trials/impact-of-robotic-approach-compared-to-vats-and-open-approach-on-quality-of-life-in-patients-with-lung-cancer-50035https://curecurrent.com/trials/a-study-of-the-correlation-between-crf-survival-and-physiological-factors-in-nsclc-patients-under-chemotherapy-50036https://curecurrent.com/trials/health-communication-in-families-50037https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-ex-vivo-expanded-autologous-immune-killer-cells-ikc-in-stage-iv-non-small-50038https://curecurrent.com/trials/congenital-lung-anomalies-cla-swiss-database-50039https://curecurrent.com/trials/anlotinib-combined-with-pemetrexed-and-carboplatin-as-first-line-treatment-in-advanced-nonsquamous-nsclc-50040https://curecurrent.com/trials/the-utility-of-circulating-tumor-cells-as-confirmation-of-pathologic-diagnosis-in-patients-with-suspected-early-stage-no-50041https://curecurrent.com/trials/correlative-study-on-cancer-patients-and-healthcare-professionals-exposed-to-infection-by-severe-acute-respiratory-syndr-50042https://curecurrent.com/trials/study-of-split-course-chemoradiotherapy-for-locally-advanced-none-small-cell-lung-cancer-50043https://curecurrent.com/trials/4d-pet-ct-in-diagnosing-participants-with-lung-and-colorectal-cancer-with-liver-and-lung-metastasis-50044https://curecurrent.com/trials/comprehensive-care-program-sbrt-50045https://curecurrent.com/trials/prognostic-pet-ct-model-in-non-small-cell-lung-cancer-50046https://curecurrent.com/trials/epidemiology-of-sars-cov-2-and-mortality-to-covid19-disease-in-french-cancer-patients-50047https://curecurrent.com/trials/mesenchymal-stem-cells-mscs-for-treatment-of-acute-respiratory-distress-syndrome-ard-in-patients-with-malignancies-50048https://curecurrent.com/trials/anti-tgf-monoclonal-antibody-gc1008-in-relapsed-malignant-pleural-mesothelioma-50049https://curecurrent.com/trials/mast-cell-activation-test-in-allergic-disease-50050https://curecurrent.com/trials/an-open-label-multicenter-phase-ii-study-of-dacomitinib-for-egfr-mutated-non-small-cell-lung-cancer-nsclc-with-brain-met-50051https://curecurrent.com/trials/t790m-mutation-testing-in-blood-by-different-methodologies-50052https://curecurrent.com/trials/assessment-of-ergonomics-in-3d-vs-2d-thoracoscopic-lobectomy-50053https://curecurrent.com/trials/glumetinib-combined-with-osimertinib-in-the-treatment-of-relapsed-and-metastatic-non-small-cell-lung-cancer-patients-who-50054https://curecurrent.com/trials/ucdcc-269-a-pilot-study-of-interlesional-il-2-and-rt-in-patients-with-nsclc-50055https://curecurrent.com/trials/the-effect-of-caphosol-on-the-development-of-esophagitis-in-n-sclc-patients-treated-with-concurrent-chemo-radiotherapy-50056https://curecurrent.com/trials/lung-heart-rate-variability-50057https://curecurrent.com/trials/lux-lung-7-a-phase-iib-trial-of-afatinib-bibw2992-versus-gefitinib-for-the-treatment-of-1st-line-egfr-mutation-positive-50058https://curecurrent.com/trials/pembrolizumab-after-lung-sbrt-for-medically-inoperable-early-stage-non-small-cell-lung-cancer-50059https://curecurrent.com/trials/ct-based-radiomic-signature-can-identify-adenocarcinoma-lung-tumor-histology-50060https://curecurrent.com/trials/efficacy-and-safety-of-anlotinib-plus-platinum-plus-pemetrexed-in-t790m-negative-nsclc-50061https://curecurrent.com/trials/fully-automated-pipeline-for-the-detection-and-segmentation-of-non-small-cell-lung-cancer-nsclc-on-ct-images-50062https://curecurrent.com/trials/liposomal-lurtotecan-plus-cisplatin-in-treating-patients-with-advanced-or-metastatic-solid-tumors-50063https://curecurrent.com/trials/gut-microbiota-and-radiotherapy-50064https://curecurrent.com/trials/paclitaxel-carboplatin-with-ut-bms-275291-in-advanced-or-metastatic-non-small-cell-lung-cancer-50065https://curecurrent.com/trials/nintedanib-compared-with-placebo-in-treating-against-radiation-induced-pneumonitis-in-patients-with-non-small-cell-lung-50066https://curecurrent.com/trials/continuous-ambulatory-ecg-monitoring-for-detection-of-postoperative-atrial-fibrillation-following-thoracic-surgery-50067https://curecurrent.com/trials/etirinotecan-pegol-nktr-102-in-nsclc-50068https://curecurrent.com/trials/lung-cancer-rehabilitation-after-medical-treatment-50069https://curecurrent.com/trials/marimastat-following-chemotherapy-in-treating-patients-with-small-cell-lung-cancer-50070https://curecurrent.com/trials/dexamethasone-sparing-approach-including-nepa-against-emesis-caused-by-cisplatin-50071https://curecurrent.com/trials/radiation-therapy-to-relieve-symptoms-in-patients-with-non-small-cell-lung-cancer-50072https://curecurrent.com/trials/vinorelbine-cisplatin-or-no-further-therapy-in-non-small-cell-lung-cancer-that-has-been-surgically-removed-50073https://curecurrent.com/trials/analysis-of-gut-microbiota-in-patients-with-brain-metastasis-of-non-small-cell-lung-cancer-treated-by-pembrolizumab-comb-50074https://curecurrent.com/trials/pazopanib-hydrochloride-in-treating-patients-with-advanced-neuroendocrine-cancer-50075https://curecurrent.com/trials/study-of-osi-774-tarceva-in-previously-untreated-elderly-lung-cancer-patients-50076https://curecurrent.com/trials/theophylline-in-treating-cancer-patients-with-shortness-of-breath-50077https://curecurrent.com/trials/s0635-erlotinib-and-bevacizumab-in-stage-iiib-and-iv-bronchioloalveolar-carcinoma-50078https://curecurrent.com/trials/flaxseed-supplement-in-treating-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-undergoing-chemo-50079https://curecurrent.com/trials/low-dose-gemcitabine-combined-with-nivolumab-for-second-line-and-above-line-treatment-of-nsclc-50080https://curecurrent.com/trials/circulating-tumor-dna-methylation-test-to-differentiate-benign-and-malignant-pulmonary-nodules-50081https://curecurrent.com/trials/esophageal-sparing-intensity-modulated-radiation-therapy-imrt-for-locally-advanced-thoracic-malignancies-50082https://curecurrent.com/trials/sirolimus-and-gold-sodium-thiomalate-in-treating-patients-with-advanced-squamous-non-small-cell-lung-cancer-50083https://curecurrent.com/trials/study-of-ct-and-mr-in-the-lung-cancer-50084https://curecurrent.com/trials/srs-study-in-patients-with-non-small-cell-lung-cancer-50085https://curecurrent.com/trials/efficacy-of-re-challenge-with-immune-checkpoints-inhibitors-in-advanced-non-small-cell-lung-cancer-patients-a-retrospect-50086https://curecurrent.com/trials/afatinib-treatment-for-patients-with-egfr-mutation-positive-nsclc-who-are-age-70-or-older-50087https://curecurrent.com/trials/evolution-of-multiple-primary-lung-cancer-evolution-50088https://curecurrent.com/trials/qualitative-study-for-pain-measurement-using-innovative-health-technology-50089https://curecurrent.com/trials/dynamic-changes-of-circulating-tumor-dna-in-surgical-lung-cancer-patients-50090https://curecurrent.com/trials/pilot-study-of-nilogen-3d-ex-and-its-ability-to-predict-therapeutic-response-to-anti-pd1-or-anti-pdl1-in-nsclc-50091https://curecurrent.com/trials/tumor-relapsed-study-of-serum-trxr-activity-in-advanced-non-small-cell-lung-cancer-50092https://curecurrent.com/trials/breaking-potentially-bad-news-in-lung-cancer-workup-telephone-versus-in-person-breaking-of-final-diagnosis-50093https://curecurrent.com/trials/validation-of-multiparametric-models-and-circulating-and-imaging-biomarkers-to-improve-lung-cancer-early-detection-50094https://curecurrent.com/trials/aprepitant-for-chemotherapy-induced-nausea-and-vomiting-in-chinese-advanced-non-small-cell-lung-cancers-50095https://curecurrent.com/trials/shox2-ptger4-dna-methlyation-in-lung-cancer-50096https://curecurrent.com/trials/cryobiopsy-versus-forceps-biopsy-for-pulmonary-lesions-50097https://curecurrent.com/trials/study-using-combined-virtual-4-d-electromagnetic-em-tip-tracked-devices-ebus-in-diagnosis-of-lung-nodules-50098https://curecurrent.com/trials/an-open-label-randomized-parallel-non-comparative-phase-ii-trial-of-nivolumab-plus-ipilimumab-versus-platinum-based-chem-50099https://curecurrent.com/trials/crizotinib-in-alk-rearranged-non-small-cell-lung-cancer-50100https://curecurrent.com/trials/the-role-of-protein-tyrosine-kinase-7-ptk7-in-non-small-cell-lung-cancer-50101https://curecurrent.com/trials/ngs-combined-with-rnaseq-on-tumor-immune-escape-in-nsclc-50102https://curecurrent.com/trials/effect-of-peep-on-subdural-pressure-optic-nerve-sheath-diameter-lung-compliance-and-brain-perfusion-pressure-50103https://curecurrent.com/trials/circulating-and-imaging-biomarkers-to-improve-lung-cancer-management-and-early-detection-50104https://curecurrent.com/trials/optimised-lung-cancer-screening-to-prevent-cardiovascular-and-pulmonary-diseases-coupled-with-primary-prevention-50105https://curecurrent.com/trials/anlotinib-in-combination-with-durvalumab-as-sequential-therapy-of-thoracic-radiotherapy-after-induction-chemotherapy-for-50106https://curecurrent.com/trials/study-on-fluids-associated-to-lung-cancer-50107https://curecurrent.com/trials/sbrt-with-s1-combined-with-endostar-in-the-treatment-of-lung-cancer-50108https://curecurrent.com/trials/lung-map-rilotumumab-and-erlotinib-hydrochloride-or-erlotinib-hydrochloride-alone-as-second-line-therapy-in-treating-pat-50109https://curecurrent.com/trials/necitumumab-in-the-neoadjuvant-setting-with-gemcitabine-in-surgically-resectable-14x-us-i001-50110https://curecurrent.com/trials/clinical-trial-of-sintilimab-combined-with-gemcitabine-carboplatin-regimen-in-the-treatment-of-advanced-primary-pulmonar-50111https://curecurrent.com/trials/modified-versus-traditional-thoracic-drainage-after-thoracoscopic-surgery-50112https://curecurrent.com/trials/investigating-the-improvement-in-4d-ct-images-using-av-biofeedback-50113https://curecurrent.com/trials/stereotactic-body-radiation-therapy-sbrt-as-a-boost-after-definitive-concurrent-chemoradiation-chemort-for-non-small-cel-50114https://curecurrent.com/trials/integrated-pulmonary-index-and-opioid-based-patient-controlled-analgesia-50115https://curecurrent.com/trials/gene-therapy-for-pleural-malignancies-50116https://curecurrent.com/trials/texture-features-and-pdl1-in-ct-pet-18-fdg-50117https://curecurrent.com/trials/local-non-salvage-radiotherapy-for-synchronous-oligometastatic-non-small-cell-lung-cancer-50118https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-amatuximab-in-combination-with-pemetrexed-and-cisplatin-in-subjects-with-unresectabl-50119https://curecurrent.com/trials/the-effect-of-spinal-stabilization-exercises-in-patients-with-myasthenia-gravis-50120https://curecurrent.com/trials/olaparib-dose-escalating-trial-concurrent-rt-with-or-without-cisplatin-in-locally-advanced-nsclc-50121https://curecurrent.com/trials/the-optimal-intervention-time-of-radiotherapy-for-oligometastatic-stage-iv-non-small-cell-lung-cancer-nsclc-50122https://curecurrent.com/trials/trial-of-cisplatin-and-kml-001-in-platinum-responsive-malignancies-50123https://curecurrent.com/trials/a-study-of-pf-05082566-as-a-single-agent-and-in-combination-with-rituximab-50124https://curecurrent.com/trials/a-study-of-prexasertib-ly2606368-in-participants-with-extensive-stage-disease-small-cell-lung-cancer-50125https://curecurrent.com/trials/pegylated-irinotecan-nktr-102-in-treating-patients-with-relapsed-small-cell-lung-cancer-50126https://curecurrent.com/trials/a-study-to-investigate-the-safety-pharmacokinetics-pharmacodynamics-and-clinical-activity-of-gsk525762-in-subjects-with-50127https://curecurrent.com/trials/a-study-of-tqb2450-injection-combined-with-stereotactic-body-radiation-therapy-sbrt-in-subjects-with-advanced-oligometas-50128https://curecurrent.com/trials/feasibility-of-re-biopsies-at-progression-50129https://curecurrent.com/trials/study-of-regn4659-in-combination-with-cemiplimab-in-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer-nscl-50130https://curecurrent.com/trials/a-study-of-rovalpituzumab-tesirine-sc16ld6-5-in-the-frontline-treatment-of-patients-with-extensive-stage-small-cell-lung-50131https://curecurrent.com/trials/a-survival-observational-study-in-patients-with-advanced-iiib-iv-squamous-cell-lung-cancer-receiving-pd-1-combination-wi-50132https://curecurrent.com/trials/trial-of-oral-karenitecin-in-patients-with-solid-tumors-and-lung-cancer-50133https://curecurrent.com/trials/evaluation-of-pd-l1-programmed-death-ligand-1-tumor-expression-in-patients-with-large-cell-neuroendocrine-carcinoma-nec-50134https://curecurrent.com/trials/oral-navelbine-and-cisplatin-followed-by-metronomic-oral-navelbine-in-non-small-cell-lung-cancer-50135https://curecurrent.com/trials/factors-determining-the-prognosis-in-nsclc-stage-iv-50136https://curecurrent.com/trials/mechanism-of-action-trial-of-coload1-50137https://curecurrent.com/trials/study-to-evaluate-real-world-pharmacoeconomics-of-crizotinib-in-nsclc-patients-50138https://curecurrent.com/trials/the-use-of-artificial-intelligence-to-predict-cancerous-lymph-nodes-for-lung-cancer-staging-during-ultrasound-imaging-50139https://curecurrent.com/trials/real-world-treatment-patterns-and-clinical-outcomes-in-egfr-mutant-unresectable-locally-advanced-nsclc-50140https://curecurrent.com/trials/metformin-as-a-chemoprevention-agent-in-non-small-cell-lung-cancer-50141https://curecurrent.com/trials/regional-haemodynamic-changes-in-radial-artery-assessment-with-continuous-pulsed-wave-doppler-ultrasound-50142https://curecurrent.com/trials/camrelizumab-combined-with-endostar-for-first-line-treatment-in-subjects-with-advanced-squamous-nsclc-50143https://curecurrent.com/trials/huaier-granule-for-prevention-of-recurrence-and-metastasis-of-stage-ii-and-iii-non-small-cell-lung-cancer-nsclc-50144https://curecurrent.com/trials/study-escalating-doses-of-pm01183-in-combination-with-fixed-doxorubicin-in-patients-with-specific-advanced-unresectable-50145https://curecurrent.com/trials/nutritional-problems-and-changes-in-body-composition-in-patients-with-non-small-cell-lung-cancer-leks-50146https://curecurrent.com/trials/s0722-everolimus-in-treating-patients-with-pleural-malignant-mesothelioma-that-cannot-be-removed-by-surgery-50147https://curecurrent.com/trials/study-of-pre-operative-combination-therapy-with-mogamulizumab-and-nivolumab-against-solid-cancer-patients-50148https://curecurrent.com/trials/s0720-adjuvant-therapy-based-on-gene-expression-in-stage-ia-and-ib-non-small-cell-lung-cancer-50149https://curecurrent.com/trials/the-safety-and-efficacy-of-fibrinolysis-in-patients-with-an-indwelling-pleural-catheter-for-multi-loculated-malignant-pl-50150https://curecurrent.com/trials/randomized-comparative-study-of-erlotinib-and-pemetrexed-in-the-maintenance-treatment-of-advanced-lung-cancer-patients-50151https://curecurrent.com/trials/a-combination-clinical-study-of-plx3397-and-pembrolizumab-to-treat-advanced-melanoma-and-other-solid-tumors-50152https://curecurrent.com/trials/s0636-erlotinib-and-bevacizumab-in-never-smokers-with-stage-iiib-or-stage-iv-primary-non-small-cell-lung-cancer-50153https://curecurrent.com/trials/cryotherapy-and-gm-csf-in-treating-patients-with-lung-metastases-or-primary-lung-cancer-50154https://curecurrent.com/trials/phase-i-study-of-a-selective-alk-inhibitor-plb1003-in-patients-with-alk-nsclc-50155https://curecurrent.com/trials/feasibility-study-of-using-navigational-bronchoscopy-to-perform-pdt-photofrin-in-unresectable-peripheral-lung-cancer-50156https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-stage-i-non-small-cell-lung-cancer-50157https://curecurrent.com/trials/phase-2-study-of-mgcd265-in-patients-with-non-small-cell-lung-cancer-with-activating-genetic-alterations-in-met-50158https://curecurrent.com/trials/tumor-cell-vaccine-for-patients-undergoing-surgery-for-sarcomas-melanomas-germ-cell-tumors-or-malignancies-that-have-met-50159https://curecurrent.com/trials/pilot-study-of-allogeneic-tumor-cell-vaccine-with-metronomic-oral-cyclophosphamide-and-celecoxib-in-patients-undergoing-50160https://curecurrent.com/trials/tumour-registry-lung-cancer-tlk-50161https://curecurrent.com/trials/chemoradiation-with-durvalumab-followed-by-durvalumab-maintenance-for-limited-disease-small-cell-lung-cancer-50162https://curecurrent.com/trials/comparison-of-post-operative-pain-and-quality-of-life-between-subxiphoid-and-intercostal-vats-for-lung-cancer-50163https://curecurrent.com/trials/intra-op-vs-pre-op-transbronchial-localization-for-small-lung-nodule-50164https://curecurrent.com/trials/18f-azafol-as-positron-emission-tomography-pet-tracer-in-fr-positive-cancer-imaging-50165https://curecurrent.com/trials/early-detection-of-lung-cancer-with-low-dose-multislice-computed-tomography-50166https://curecurrent.com/trials/a-trial-of-cv301-in-combination-with-anti-pd-1-therapy-in-subjects-with-non-small-cell-lung-cancer-50167https://curecurrent.com/trials/the-real-world-study-of-neoadjuvant-immunotherapy-in-early-stage-nsclc-in-china-50168https://curecurrent.com/trials/study-in-patients-with-tumours-requiring-arginine-to-assess-adi-peg-20-with-atezolizumab-pemetrexed-and-carboplatin-50169https://curecurrent.com/trials/pd-1-combined-with-dasatinib-for-as-third-line-treatment-for-arid1a-mutation-advanced-nsclc-50170https://curecurrent.com/trials/positron-emission-tomography-magnetic-resonance-imaging-in-patients-50171https://curecurrent.com/trials/establishment-of-a-pdt-patient-registry-50172https://curecurrent.com/trials/a-safety-and-efficacy-study-of-inc280-alone-and-in-combination-with-erlotinib-compared-to-chemotherapy-in-advanced-metas-50173https://curecurrent.com/trials/blood-based-identification-and-monitoring-of-patients-with-alk-translocated-lung-cancer-50174https://curecurrent.com/trials/egfr-molecular-classification-in-vivo-50175https://curecurrent.com/trials/thoracic-re-irradiation-for-locoregionally-recurrent-non-small-cell-lung-cancer-50176https://curecurrent.com/trials/comparative-trial-of-home-based-palliative-care-50177https://curecurrent.com/trials/s0709-erlotinib-with-or-without-carboplatin-and-paclitaxel-in-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-50178https://curecurrent.com/trials/a-prospective-study-of-electronic-symptom-reporting-via-mobile-phone-among-patients-with-advanced-non-small-cell-lung-ca-50179https://curecurrent.com/trials/s1300-pemetrexed-disodium-with-or-without-crizotinib-in-treating-patients-with-stage-iv-non-small-cell-lung-cancer-that-50180https://curecurrent.com/trials/pathological-and-nuclear-medicine-factors-for-prognosis-in-lung-carcinoma-50181https://curecurrent.com/trials/a-study-of-ly3200882-and-pembrolizumab-in-participants-with-advanced-cancer-50182https://curecurrent.com/trials/transbronchial-ablation-for-peripheral-lung-tumor-50183https://curecurrent.com/trials/gefitinib-versus-vinorelbine-platinum-as-adjuvant-treatment-in-stage-ii-iiia-n1-n2-nsclc-with-egfr-mutation-50184https://curecurrent.com/trials/immune-related-adverse-events-in-patients-receiving-immune-checkpoint-inhibitors-50185https://curecurrent.com/trials/apatinib-combined-with-vinorelbine-for-non-driver-gene-mutation-non-small-cell-lung-cancer-50186https://curecurrent.com/trials/advanced-non-small-cell-lung-cancer-progressing-after-at-least-one-prior-therapy-for-metastatic-disease-50187https://curecurrent.com/trials/cancer-genome-atlas-of-china-lung-cancer-50188https://curecurrent.com/trials/imaging-fib-one-in-the-human-lung-using-endomicroscopy-50189https://curecurrent.com/trials/a-clinical-trial-of-fruquintinib-in-patients-with-advanced-non-small-cell-lung-cancer-50190https://curecurrent.com/trials/early-detection-of-lung-cancer-in-a-high-risk-population-defined-by-pft-biomarkers-and-ct-scanning-50191https://curecurrent.com/trials/docetaxel-in-treating-older-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-50192https://curecurrent.com/trials/paclitaxel-liposome-for-squamous-non-small-cell-lung-cancer-study-lipusu-50193https://curecurrent.com/trials/multicenter-observational-study-of-advanced-non-small-cell-lung-cancer-with-malignant-pleural-effusion-50194https://curecurrent.com/trials/analysis-of-driver-gene-mutation-in-early-stage-non-small-cell-lung-cancer-50195https://curecurrent.com/trials/pemetrexed-vs-pemetrexed-plus-cisplatin-in-egfr-mutant-nsclc-patients-after-first-line-egfr-tkis-failure-50196https://curecurrent.com/trials/physical-activity-and-inactivity-in-lung-cancer-survivors-50197https://curecurrent.com/trials/cisplatin-etoposide-concurrent-zd6474-in-previously-untreated-extensive-stage-small-cell-lung-cancer-50198https://curecurrent.com/trials/computed-tomography-assessment-of-regional-ventilation-curve-50199https://curecurrent.com/trials/phase-i-study-in-chinese-nsclc-patients-50200https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-alectinib-in-participants-with-anaplastic-lymphoma-kinase-alk-rearranged-non-small-50201https://curecurrent.com/trials/pembrolizumab-and-paclitaxel-in-refractory-small-cell-lung-cancer-50202https://curecurrent.com/trials/pilot-study-of-intra-arterial-cisplatin-with-iv-thiosulfate-in-patients-with-lung-cancer-or-lung-metastases-50203https://curecurrent.com/trials/bevacizumab-versus-docetaxel-erlotinib-on-tumor-metrics-in-patients-with-previously-untreated-advanced-non-small-cell-lu-50204https://curecurrent.com/trials/a-study-for-reducing-symptom-burden-produced-by-chemoradiation-treatment-for-non-small-cell-lung-cancer-by-minocycline-a-50205https://curecurrent.com/trials/rh-endostatin-combined-with-chemotherapy-and-pembrolizumab-for-advanced-nsclc-50206https://curecurrent.com/trials/azacitidine-in-treating-patients-with-stage-iv-or-recurrent-non-small-cell-lung-cancer-50207https://curecurrent.com/trials/study-of-the-correlation-of-tumor-tissue-microbiome-to-the-pathogenesis-of-lung-cancer-50208https://curecurrent.com/trials/a-real-world-study-based-on-ngs-trumprws-50209https://curecurrent.com/trials/third-line-treatment-of-gefitinib-in-nsclc-patients-50210https://curecurrent.com/trials/improving-clinical-trial-awareness-in-nsclc-pilot-testing-a-novel-healthcare-it-platform-for-incorporating-education-at-50211https://curecurrent.com/trials/ts-overexpression-in-sclc-mechanism-and-therapeutic-targeting-50212https://curecurrent.com/trials/a-phase-2-study-of-viagenpumatucel-l-hs-110-in-patients-with-non-small-cell-lung-cancer-50213https://curecurrent.com/trials/this-phase-ii-iii-multicenter-study-is-designed-to-evaluate-the-safety-and-clinical-activity-of-al3810-in-patients-50214https://curecurrent.com/trials/multiplex-analysis-of-circulating-tumor-dna-50215https://curecurrent.com/trials/dmh-based-plan-evaluation-and-inverse-optimization-in-radiotherapy-50216https://curecurrent.com/trials/irinotecan-plus-lobaplatin-versus-irinotecan-in-the-second-line-treatment-of-small-cell-lung-cancer-50217https://curecurrent.com/trials/a-trial-of-shr-1210-an-anti-pd-1-inhibitor-in-combination-with-hypofraction-radiotherapy-in-patients-with-nsclc-50218https://curecurrent.com/trials/sintilimab-versus-pembrolizumab-for-advanced-stage-non-small-cell-lung-cancer-50219https://curecurrent.com/trials/a-comprehensive-evaluation-of-circulating-tumor-dna-and-circulating-tumor-cells-as-a-predictive-marker-in-lung-cancer-50220https://curecurrent.com/trials/etoposide-plus-lobaplatin-versus-etoposide-plus-cisplatin-for-patients-with-limited-small-cell-lung-cancer-50221https://curecurrent.com/trials/therapeutic-resistance-and-clonal-evolution-assessed-with-liquid-biopsy-of-nsclc-patients-in-china-50222https://curecurrent.com/trials/durvalumab-combined-with-chemotherapy-and-stereotactic-body-radiotherapy-sbrt-in-patients-with-oligometastatic-non-small-50223https://curecurrent.com/trials/a-study-of-nivo-plus-ipi-and-guadecitabine-or-nivo-plus-ipi-in-melanoma-and-nsclc-resistant-to-anti-pd1-pdl1-50224https://curecurrent.com/trials/serratus-anterior-plane-block-versus-intercostal-nerve-block-for-postoperative-analgesia-50225https://curecurrent.com/trials/lungtech-stereotactic-body-radiotherapy-sbrt-of-inoperable-centrally-located-nsclc-50226https://curecurrent.com/trials/early-hippocampal-avoidance-prophylactic-cranial-irradiation-in-patients-with-ld-sclc-50227https://curecurrent.com/trials/optimization-of-smoking-cessation-strategies-concurrent-with-treatment-of-tobacco-related-malignancies-50228https://curecurrent.com/trials/battle-program-tarceva-and-targretin-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-50229https://curecurrent.com/trials/anticancer-activity-of-nicotinamide-on-lung-cancer-50230https://curecurrent.com/trials/a-positron-emission-tomography-pet-imaging-agent-18f-ods2004436-as-a-marker-of-egfr-mutation-in-subjects-with-nsclc-50231https://curecurrent.com/trials/pcori-cer-1306-03385-lung-cancer-screening-readiness-study-50232https://curecurrent.com/trials/ultrasonic-energy-for-pulmonary-artery-branch-sealing-during-vats-lobectomy-50233https://curecurrent.com/trials/a-study-of-sh-1028-tablets-versus-gefitinib-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-50234https://curecurrent.com/trials/clinical-study-of-pd-1-monoclonal-antibody-shr-1210-and-apatinib-in-advanced-nsclc-soft-tissue-sarcoma-and-uterine-cance-50235https://curecurrent.com/trials/feasibility-of-the-research-for-mutation-of-k-ras-and-egfr-in-ctcs-from-metastatic-non-small-cells-bronchial-carcinomas-50236https://curecurrent.com/trials/health-outcomes-of-recently-diagnosed-myelodysplastic-syndrome-mds-chronic-myelomonocytic-leukemia-cmml-patients-dependi-50237https://curecurrent.com/trials/phase-1-study-of-fusilev-to-prevent-or-reduce-mucositis-in-patients-with-non-small-cell-lung-cancer-receiving-folotyn-50238https://curecurrent.com/trials/atreus-phase-ii-study-on-the-activity-of-trabectedin-in-patients-with-malignant-pleural-mesothelioma-mpm-50239https://curecurrent.com/trials/a-study-of-tqb2450-or-placebo-combined-with-anlotinib-etoposide-and-carboplatin-versus-etoposide-and-carboplatin-in-subj-50240https://curecurrent.com/trials/thoracic-surgery-combined-with-intrathoracic-hyperthermic-perfusion-for-advanced-lung-cancer-esophageal-cancer-50241https://curecurrent.com/trials/benefits-of-pulmonary-rehabilitation-in-patients-with-severe-lymphangioleiomyomatosis-lam-50242https://curecurrent.com/trials/low-dose-chest-computed-tomography-screening-for-lung-cancer-in-survivors-of-hodgkin-s-disease-50243https://curecurrent.com/trials/a-placebo-controlled-study-of-saracatinib-azd0530-in-patients-with-recurrent-osteosarcoma-localized-to-the-lung-50244https://curecurrent.com/trials/high-flow-nasal-cannula-vs-nppv-in-moderate-chronic-obstructive-pulmonary-disease-exacerbation-50245https://curecurrent.com/trials/extracorporeal-carbon-dioxide-removal-in-severe-chronic-obstructive-pulmonary-disease-exacerbation-50246https://curecurrent.com/trials/omega-local-ablative-therapy-in-oligometastatic-nsclc-50247https://curecurrent.com/trials/respiratory-support-in-severe-chronic-obstructive-pulmonary-disease-exacerbation-50248https://curecurrent.com/trials/hfnc-vs-nasal-cannula-in-mild-chronic-obstructive-pulmonary-disease-exacerbation-50249https://curecurrent.com/trials/low-dose-acetylsalicylic-acid-in-treating-patients-with-stage-i-iii-non-small-cell-lung-cancer-50250https://curecurrent.com/trials/evaluation-of-the-cell-detachment-ratio-on-ph-responsive-chitosan-as-a-prognostic-factor-in-lung-cancer-50251https://curecurrent.com/trials/battle-program-umbrella-protocol-for-patients-with-non-small-cell-lung-cancer-nsclc-50252https://curecurrent.com/trials/safety-of-pdt-photofrin-prior-to-lung-surgery-50253https://curecurrent.com/trials/phase-iii-trial-bi-695502-plus-chemotherapy-vs-avastin-plus-chemotherapy-in-patients-with-lung-cancer-50254https://curecurrent.com/trials/a-study-to-optimize-care-for-lung-cancer-patients-undergoing-video-assisted-thoracoscopic-surgery-vats-50255https://curecurrent.com/trials/feasibility-of-multi-energy-digital-radiography-detector-for-lung-lesions-detection-50256https://curecurrent.com/trials/enb-guided-mwa-for-early-stage-peripheral-lung-cancer-50257https://curecurrent.com/trials/collaborative-advanced-stage-tissue-lung-cancer-castle-network-50258https://curecurrent.com/trials/giotrif-in-first-line-therapy-of-advanced-nsclc-with-egfr-mutations-50259https://curecurrent.com/trials/pdx-models-from-egfr-mutant-tumors-50260https://curecurrent.com/trials/x-396-capsule-in-advanced-nsclc-patients-with-ros1-gene-rearrangement-50261https://curecurrent.com/trials/anlotinib-plus-docetaxel-for-the-treatment-of-egfr-wild-type-advanced-non-small-cell-lung-cancer-50262https://curecurrent.com/trials/effects-of-different-ventilation-patterns-on-lung-injury-50263https://curecurrent.com/trials/a-prospective-cohort-of-pulmonary-ground-glass-nodules-patients-with-family-history-50264https://curecurrent.com/trials/a-study-of-atezolizumab-in-participants-with-programmed-death-ligand-1-pd-l1-positive-locally-advanced-or-metastatic-non-50265https://curecurrent.com/trials/mtd-study-pxd-101-in-combination-with-paclitaxel-carboplatin-in-chemotherapy-naive-patients-with-stage-iv-nsclc-50266https://curecurrent.com/trials/prevention-of-tumor-spread-due-to-lung-cancer-surgery-50267https://curecurrent.com/trials/metformin-in-non-small-cell-lung-cancer-nsclc-50268https://curecurrent.com/trials/anlotinib-combined-with-sintilimab-as-second-line-treatment-or-beyond-in-patients-with-small-cell-lung-cancer-50269https://curecurrent.com/trials/quality-of-life-in-lung-cancer-survivors-50270https://curecurrent.com/trials/hatha-yoga-in-lung-cancer-couples-50271https://curecurrent.com/trials/study-of-hypofractionated-proton-radiation-therapy-in-thoracic-malignancies-50272https://curecurrent.com/trials/integrative-analysis-of-pulmonary-sarcomatoid-carcinoma-psc-50273https://curecurrent.com/trials/lisinopril-in-reducing-shortness-of-breath-caused-by-radiation-therapy-in-patients-with-lung-cancer-50274https://curecurrent.com/trials/study-to-test-the-efficacy-of-the-vaccine-gsk-249553-in-treating-non-small-cell-lung-cancer-after-tumour-removal-by-surg-50275https://curecurrent.com/trials/early-cancer-detection-test-lung-cancer-china-50276https://curecurrent.com/trials/psychological-and-physical-distress-and-care-needs-in-operable-lung-cancer-patients-receiving-surgery-50277https://curecurrent.com/trials/sintilimab-combined-with-bevacizumab-for-brain-metastases-from-non-small-cell-lung-cancer-50278https://curecurrent.com/trials/sleep-apnea-and-lung-cancer-50279https://curecurrent.com/trials/nab-paclitaxel-versus-topotecan-as-second-line-treatment-for-patients-with-extensive-stage-small-cell-lung-cancer-50280https://curecurrent.com/trials/osi-774-erlotinib-tarceva-in-elderly-patients-50281https://curecurrent.com/trials/a-multiple-ascending-dose-study-of-medi7247-in-advanced-or-metastatic-solid-tumors-50282https://curecurrent.com/trials/dacomitinib-pemetrexed-for-patients-with-advanced-non-squamous-non-small-cell-lung-cancer-nsclc-50283https://curecurrent.com/trials/a-study-of-ly3009120-in-participants-with-advanced-cancer-or-cancer-that-has-spread-to-other-parts-of-their-body-50284https://curecurrent.com/trials/multicenter-observational-study-of-chinese-non-small-cell-lung-cancer-nsclc-patients-with-rare-driver-gene-mutation-50285https://curecurrent.com/trials/anlotinib-combined-with-nivolumab-for-non-small-cell-lung-cancer-50286https://curecurrent.com/trials/observational-study-with-metronomic-oral-vinorelbine-in-elderly-patients-with-locally-advanced-metastatic-non-small-cell-50287https://curecurrent.com/trials/efficacy-safety-and-pharmacokinetics-study-of-antroquinonol-to-treat-nsclc-50288https://curecurrent.com/trials/chromosomal-instability-as-a-surrogate-biomarker-of-drug-resistance-in-immunotherapy-for-lung-cancer-patients-50289https://curecurrent.com/trials/ponatinib-in-advanced-nsclc-w-ret-translocations-50290https://curecurrent.com/trials/a-study-of-erlotinib-in-participants-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-50291https://curecurrent.com/trials/a-study-of-atezolizumab-compared-with-docetaxel-in-participants-with-locally-advanced-or-metastatic-non-small-cell-lung-50292https://curecurrent.com/trials/trial-of-photodynamic-therapy-versus-argon-plasma-coagulation-for-lung-cancer-with-endobronchial-obstruction-50293https://curecurrent.com/trials/to-explore-the-related-factors-of-cough-after-thoracoscopic-pneumonectomy-50294https://curecurrent.com/trials/a-phase-3-study-of-ibrutinib-pci-32765-versus-ofatumumab-in-patients-with-relapsed-or-refractory-chronic-lymphocytic-leu-50295https://curecurrent.com/trials/evaluation-of-cancer-care-coordination-in-the-national-cancer-institutes-community-cancer-center-programs-50296https://curecurrent.com/trials/ct-controlled-advanced-navigation-techniques-for-transbronchial-pulmonary-lesion-access-evaluation-of-electromagnetic-na-50297https://curecurrent.com/trials/amatuximab-for-high-mesothelin-cancers-50298https://curecurrent.com/trials/ct-controlled-advanced-navigation-techniques-for-transbronchial-pulmonary-lesion-access-evaluation-of-augmented-fluorosc-50299https://curecurrent.com/trials/erlotinib-in-women-with-previously-untreated-adenocarcinoma-of-the-lung-50300https://curecurrent.com/trials/cryoablation-combined-with-camrelizumab-and-apatinib-for-multiprimary-lung-cancer-50301https://curecurrent.com/trials/02341066-and-pf-00299804-for-advanced-non-small-cell-lung-cancer-50302https://curecurrent.com/trials/e-predict-ebus-elastography-strain-in-lung-cancer-50303https://curecurrent.com/trials/evaluating-combination-therapy-using-autologous-dendritic-cells-pulsed-with-antigen-peptides-and-nivolumab-for-subjects-50304https://curecurrent.com/trials/hypofractionated-radiotherapy-for-lung-cancer-50305https://curecurrent.com/trials/bortezomib-with-or-without-docetaxel-in-treating-patients-with-relapsed-or-refractory-advanced-non-small-cell-lung-cance-50306https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-in-participants-with-progressive-locally-advanced-or-metastatic-carcinoma-melanoma-or-non-50307https://curecurrent.com/trials/psychometric-properties-of-the-eortc-qlq-lc29-50308https://curecurrent.com/trials/vorinostat-and-bortezomib-as-third-line-treatment-in-advanced-non-small-cell-lung-cancer-50309https://curecurrent.com/trials/pilot-study-of-61-cuatsm-pet-imaging-in-cancer-patients-50310https://curecurrent.com/trials/depsipeptide-flavopiridol-infusion-for-cancers-of-the-lungs-esophagus-pleura-thymus-or-mediastinum-50311https://curecurrent.com/trials/multimodal-prehabilitation-in-thoracic-surgery-50312https://curecurrent.com/trials/autologous-car-t-tcr-t-cell-immunotherapy-for-malignancies-50313https://curecurrent.com/trials/a-real-world-study-for-patients-with-multiple-pulmonary-ground-glass-nodules-50314https://curecurrent.com/trials/the-role-of-brain-radiotherapy-in-patients-with-asymptomatic-brain-metastasis-in-the-era-of-targeted-therapy-for-nsclc-50315https://curecurrent.com/trials/an-exploration-of-apatinib-combined-with-s-1-in-patients-with-advanced-non-small-cell-lung-cancer-50316https://curecurrent.com/trials/chemotherapy-with-pembrolizumab-continuation-after-progression-to-pd-1-l1-inhibitors-50317https://curecurrent.com/trials/analysis-of-re-biopsy-specimens-in-advanced-nsclc-with-acquired-resistance-of-egfr-tki-targeted-therapy-50318https://curecurrent.com/trials/investigation-of-gsk2879552-in-subjects-with-relapsed-refractory-small-cell-lung-carcinoma-50319https://curecurrent.com/trials/chemoradiotherapy-with-or-without-sintilimab-in-limited-stage-sclc-50320https://curecurrent.com/trials/echocardiography-for-rili-prediction-50321https://curecurrent.com/trials/the-protective-ventilation-using-open-lung-approach-or-not-trial-50322https://curecurrent.com/trials/tumor-cell-vaccines-with-iscomatrix-adjuvant-and-celecoxib-in-patients-undergoing-resection-of-lung-and-esophageal-cance-50323https://curecurrent.com/trials/trametinib-in-patients-with-advanced-neurofibromatosis-type-1-nf1-mutant-non-small-cell-lung-cancer-50324https://curecurrent.com/trials/clinical-study-of-ctdna-and-exosome-combined-detection-to-identify-benign-and-malignant-pulmonary-nodules-50325https://curecurrent.com/trials/bronchoscopic-icg-injection-and-percutaneous-hook-wire-techniques-for-preoperative-lung-nodule-localization-in-vats-50326https://curecurrent.com/trials/study-of-anlotinib-plus-chemoradiotherapy-in-patients-with-locally-advanced-nsclc-50327https://curecurrent.com/trials/stereotactic-body-radiation-therapy-sbrt-in-metastatic-non-small-cell-lung-cancer-50328https://curecurrent.com/trials/a-study-of-neoadjuvant-chemotherapy-plus-anlotinib-in-stage-iii-n2-non-small-cell-lung-cancer-50329https://curecurrent.com/trials/a-study-of-lobaplatin-etoposide-with-or-without-anlotinib-maintenance-therapy-in-patients-with-es-sclc-50330https://curecurrent.com/trials/srs-sequential-sindilimab-in-brain-metastasis-of-nslsc-50331https://curecurrent.com/trials/treatment-of-locally-advanced-non-small-cell-lung-cancer-nsclc-50332https://curecurrent.com/trials/sirolimus-and-pemetrexed-to-treat-non-small-cell-lung-cancer-50333https://curecurrent.com/trials/evaluation-and-long-term-follow-up-of-patients-with-allergic-and-inflammatory-disorders-50334https://curecurrent.com/trials/rapid-plasma-genotyping-for-early-initiation-of-erlotinib-in-egfr-mutant-lung-cancer-50335https://curecurrent.com/trials/first-in-human-phase-i-study-of-a-selective-c-met-inhibitor-plb1001-50336https://curecurrent.com/trials/phase-iii-study-of-nazartinib-egf816-versus-erlotinib-gefitinib-in-first-line-locally-advanced-metastatic-nsclc-with-egf-50337https://curecurrent.com/trials/clinical-trial-in-chinese-healthy-volunteers-of-gb222-50338https://curecurrent.com/trials/a-study-to-evaluate-camrelizumab-in-combination-with-nb-paclitaxel-in-patients-with-advanced-or-metastatic-nsclc-50339https://curecurrent.com/trials/frequency-of-egfr-mutations-in-latinos-hispanics-with-non-small-cell-lung-cancer-50340https://curecurrent.com/trials/mecapegfilgrastim-prevents-neutropenia-and-radiation-esophagitis-50341https://curecurrent.com/trials/fluorescence-bronchoscopy-and-molecular-characterization-of-abnormal-bronchial-lesions-novel-approaches-for-early-detect-50342https://curecurrent.com/trials/tarceva-erlotinib-in-combination-with-chemoradiation-in-patients-with-stage-iiia-b-non-small-cell-lung-cancer-nsclc-50343https://curecurrent.com/trials/comparison-of-the-duration-of-ropivacaine-combined-with-dexmedetomidine-or-dexamethasone-on-paravertebral-block-50344https://curecurrent.com/trials/a-study-of-daratumumab-in-combination-with-atezolizumab-compared-with-atezolizumab-alone-in-participants-with-previously-50345https://curecurrent.com/trials/study-of-amrubicin-with-or-without-cisplatin-versus-etoposide-cisplatin-for-extensive-stage-small-cell-lung-cancer-50346https://curecurrent.com/trials/a-phase-i-ii-study-to-determine-the-maximum-tolerated-dose-mtd-and-safety-of-cc-4047-pomalidomide-administered-in-conjun-50347https://curecurrent.com/trials/erlotinib-and-sunitinib-in-nsclc-50348https://curecurrent.com/trials/the-influence-of-csrt-led-telephone-follow-up-on-esas-scores-in-patients-who-have-been-treated-with-lung-sbrt-50349https://curecurrent.com/trials/adjuvant-cisplatin-and-docetaxel-in-non-small-cell-lung-cancer-50350https://curecurrent.com/trials/study-of-fruquintinib-hmpl-013-in-high-risk-patients-with-advanced-nsclc-50351https://curecurrent.com/trials/watchful-observation-of-patients-with-ld-sclc-instead-of-the-pci-50352https://curecurrent.com/trials/validation-of-a-comprehensive-health-status-assessment-scale-in-elderly-patients-65-years-with-hematological-malignancie-50353https://curecurrent.com/trials/dose-escalation-of-bevacizumab-with-ambulatory-blood-pressure-monitoring-in-patients-with-advanced-non-squamous-nsclc-50354https://curecurrent.com/trials/fluorescence-navigated-thoracoscopy-for-detection-of-small-pulmonary-nodules-50355https://curecurrent.com/trials/safety-and-pk-study-of-cc-90003-in-relapsed-refractory-solid-tumors-50356https://curecurrent.com/trials/impacts-of-exercise-on-prognostic-biomarkers-in-lung-cancer-patients-50357https://curecurrent.com/trials/evaluating-an-interactive-cancer-communication-system-iccs-in-lung-cancer-50358https://curecurrent.com/trials/intra-patient-dose-escalation-study-of-sorafenib-in-advanced-non-small-cell-lung-cancer-50359https://curecurrent.com/trials/a-phase-ii-study-of-fruquintinib-in-combination-with-gefitinib-in-patients-with-advanced-non-small-cell-lung-cancer-50360https://curecurrent.com/trials/surveillance-for-new-lung-primaries-50361https://curecurrent.com/trials/fast-track-rehabilitation-50362https://curecurrent.com/trials/efficacy-and-safety-study-of-anlotinib-with-pembrolizumab-in-adults-with-programmed-cell-death-ligand-1-pd-l1-positive-t-50363https://curecurrent.com/trials/ganetespib-with-platinum-in-patients-with-malignant-pleural-mesothelioma-50364https://curecurrent.com/trials/endostar-combined-with-concurrent-radiochemotherapy-for-treatment-of-unresectable-stage-iii-nsclc-50365https://curecurrent.com/trials/multimodal-intervention-for-patients-with-non-small-cell-lung-cancer-50366https://curecurrent.com/trials/study-assessing-safety-pharmacokinetics-and-efficacy-of-cc-223-with-either-erlotinib-or-oral-azacitidine-in-advanced-non-50367https://curecurrent.com/trials/blood-sample-monitoring-of-patients-with-egfr-mutated-lung-cancer-50368https://curecurrent.com/trials/an-open-label-study-in-patients-with-advanced-nsclc-with-abi-007-abraxane-in-combination-with-carboplatin-50369https://curecurrent.com/trials/a-phase-1-study-of-cc-486-as-a-single-agent-and-in-combination-with-carboplatin-or-abi-007-in-subjects-with-relapsed-or-50370https://curecurrent.com/trials/ngs-based-large-panel-in-targeted-drug-delivery-and-immunotherapy-of-lung-cancer-50371https://curecurrent.com/trials/study-of-the-concentration-effect-relationship-of-nivolumab-in-patients-with-kidney-or-lung-cancer-50372https://curecurrent.com/trials/gefitinib-in-combination-with-anlotinib-or-placebo-in-previously-untreated-egfr-mutant-nsclc-50373https://curecurrent.com/trials/to-immunize-patients-with-extensive-stage-sclc-combined-with-chemo-with-or-without-all-trans-retinoic-acid-50374https://curecurrent.com/trials/validation-of-molecular-diagnostic-thecnologies-for-lung-cancer-patients-50375https://curecurrent.com/trials/study-of-lung-cancer-in-appalachian-kentucky-the-role-of-environmental-carcinogens-50376https://curecurrent.com/trials/construction-and-evaluation-of-the-liquid-biopsy-based-early-diagnostic-model-for-lung-cancer-50377https://curecurrent.com/trials/phase-ib-study-of-anetumab-ravtansine-in-combination-with-pemetrexed-and-cisplatin-in-mesothelin-expressing-solid-tumors-50378https://curecurrent.com/trials/azd1775-combined-with-olaparib-in-patients-with-refractory-solid-tumors-50379https://curecurrent.com/trials/resistance-activating-mutations-diagnosed-among-nsclc-community-dwelling-egfr-mutation-positive-patients-50380https://curecurrent.com/trials/pembrolizumab-platinum-doublets-without-radiation-for-programmed-death-ligand-1-pd-l1-50-locally-advanced-nsclc-50381https://curecurrent.com/trials/hypofractionated-accelerated-radiotherapy-with-concomitant-chemotherapy-for-nsclc-50382https://curecurrent.com/trials/lucid-lung-cancer-circulating-tumour-dna-study-50383https://curecurrent.com/trials/amr-ph-gl-2007-cl001-phase-3-trial-in-patients-with-small-cell-lung-cancer-after-failure-of-first-line-chemotherapy-50384https://curecurrent.com/trials/effect-on-patient-reported-outcomes-of-vats-and-sabr-lilac-50385https://curecurrent.com/trials/study-of-chemotherapy-combination-with-autologous-cytokine-induced-killer-cell-immunotherapy-to-treat-lung-cancer-50386https://curecurrent.com/trials/osimertinib-with-or-without-bevacizumab-for-egfr-mutant-non-small-cell-lung-cancer-with-leptomeningeal-metastasis-50387https://curecurrent.com/trials/a-study-of-famitinib-in-patients-with-advanced-non-squamous-and-non-small-cell-lung-cancer-nsclc-50388https://curecurrent.com/trials/expanded-access-for-lorlatinib-for-patients-with-non-small-cell-lung-cancer-alk-positive-or-ros1-positive-50389https://curecurrent.com/trials/evaluation-of-the-archimedes-system-for-transparenchymal-nodule-access-2-50390https://curecurrent.com/trials/feasibility-study-of-the-rf-ablation-catheter-to-ablate-lung-tumors-50391https://curecurrent.com/trials/a-phase-1b-study-of-medi4736-in-combination-with-tremelimumab-in-subjects-with-advanced-non-small-cell-lung-cancer-50392https://curecurrent.com/trials/study-of-tqb2450-combined-with-anlotinib-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-50393https://curecurrent.com/trials/study-of-tq-b3139-versus-crizotinib-in-the-first-line-treatment-of-subjects-with-anaplastic-lymphoma-kinase-alk-positive-50394https://curecurrent.com/trials/sputum-labeling-utilizing-synthetic-meso-tetra-4-carboxyphenyl-porphine-tcpp-for-detection-of-lung-cancer-50395https://curecurrent.com/trials/0822gcc-phase-2-study-of-efficacy-and-safety-of-apricoxib-placebo-with-docetaxel-or-pemetrexed-in-non-small-cell-lung-ca-50396https://curecurrent.com/trials/a-single-dose-comparativebioavailability-study-oftwo-formulations-oferlotinib150mgtabletsunderfastingconditions-50397https://curecurrent.com/trials/study-of-tq-b3139-in-subjects-with-anaplastic-lymphoma-kinase-alk-positive-non-small-cell-lung-cancer-nsclc-previously-t-50398https://curecurrent.com/trials/arsenic-exposure-and-lung-cancer-incidence-50399https://curecurrent.com/trials/albumin-bound-paclitaxel-abi-007-for-patients-with-advanced-non-small-cell-lung-cancer-50400https://curecurrent.com/trials/alectinib-versus-pemetrexed-or-docetaxel-in-anaplastic-lymphoma-kinase-alk-positive-advanced-non-small-cell-lung-cancer-50401https://curecurrent.com/trials/safety-pharmacokinetic-and-preliminary-efficacy-study-of-ac0010ma-in-advanced-non-small-cell-lung-cancer-50402https://curecurrent.com/trials/physiotherapy-prehabilitation-in-patients-undergoing-cardiac-or-thoracic-surgery-50403https://curecurrent.com/trials/study-of-trc105-paclitaxel-carboplatin-and-bevacizumab-in-patients-with-nsclc-50404https://curecurrent.com/trials/a-study-of-necitumumab-in-the-first-line-treatment-of-stage-iv-squamous-non-small-cell-lung-cancer-nsclc-50405https://curecurrent.com/trials/study-of-amrubicin-in-patients-with-small-cell-lung-cancer-refractory-or-progressive-to-prior-therapy-50406https://curecurrent.com/trials/study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-single-ascending-dose-of-zsp1603-in-healthy-adults-50407https://curecurrent.com/trials/study-of-veliparib-in-combination-with-nivolumab-and-platinum-doublet-chemotherapy-in-participants-with-metastatic-or-ad-50408https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-pharmacodynamics-of-an-anti-pd-1-mab-for-patients-with-advanced-solid-tumors-50409https://curecurrent.com/trials/immunodeficiency-in-cartilage-hair-hypoplasia-sub-project-on-safety-of-vaccination-against-chickenpox-50410https://curecurrent.com/trials/phase-ii-study-of-sorafenib-carboplatin-and-docetaxel-in-first-line-treatment-of-stage-iiib-iv-nsclc-50411https://curecurrent.com/trials/clinical-study-of-anlotinib-in-maintenance-treatment-of-advanced-nsclc-50412https://curecurrent.com/trials/apatinib-combined-with-shr-1210-injection-in-the-treatment-of-patients-with-removable-ib-iiia-nsclc-50413https://curecurrent.com/trials/t-cell-pet-imaging-with-18f-f-arag-in-lung-cancer-50414https://curecurrent.com/trials/phase-ii-study-with-cabozantinib-in-patients-with-ret-positive-nsclc-50415https://curecurrent.com/trials/surgery-with-or-without-internal-radiation-therapy-in-treating-patients-with-stage-i-non-small-cell-lung-cancer-50416https://curecurrent.com/trials/phase-i-ii-trial-of-rhenium-188-p2045-in-small-cell-lung-cancer-and-other-advanced-neuroendocrine-carcinomas-50417https://curecurrent.com/trials/functional-imaging-in-lung-sbrt-50418https://curecurrent.com/trials/appatinib-combined-with-s-1-in-the-treatment-of-small-cell-lung-cancer-50419https://curecurrent.com/trials/egfr-tki-combined-with-concurrent-or-sequential-chemotherapy-for-patients-of-gradual-progression-50420https://curecurrent.com/trials/using-imaging-and-molecular-markers-to-predict-tumor-response-and-lung-toxicity-in-lung-cancer-50421https://curecurrent.com/trials/clinical-evaluation-of-vagal-nerve-preservation-in-minimally-invasive-surgery-for-early-lung-cancer-50422https://curecurrent.com/trials/car-t-cell-receptor-immunotherapy-targeting-mesothelin-for-patients-with-metastatic-cancer-50423https://curecurrent.com/trials/combination-therapy-of-sintilimab-and-anlotinib-as-a-first-line-treatment-in-advanced-nsclc-sunrise-50424https://curecurrent.com/trials/registry-of-guardant360-use-and-outcomes-in-people-with-advanced-cancer-50425https://curecurrent.com/trials/deuterated-phenanthrene-tetraol-in-smokers-who-are-at-high-risk-for-lung-cancer-50426https://curecurrent.com/trials/prospective-analysis-of-genotypes-in-adults-undergoing-therapy-for-lung-cancer-50427https://curecurrent.com/trials/mitigation-of-radiation-pneumonitis-and-fibrosis-50428https://curecurrent.com/trials/international-registry-of-patients-treated-with-pressurized-intraperitoneal-aerosol-chemotherapy-pipac-50429https://curecurrent.com/trials/efficacy-and-safety-of-the-combination-of-anlotinib-and-js001-in-egfr-tki-resistant-t790m-negative-nsclc-50430https://curecurrent.com/trials/early-diagnosis-of-lung-cancer-and-mesothelioma-in-prior-asbestos-workers-50431https://curecurrent.com/trials/a-dose-escalation-study-in-adult-patients-with-advanced-solid-malignancies-50432https://curecurrent.com/trials/pdr001-panobinostat-for-melanoma-and-nsclc-50433https://curecurrent.com/trials/phase-i-dose-escalation-study-of-azd4785-in-patients-with-advanced-solid-tumours-50434https://curecurrent.com/trials/study-of-ngr-htnf-in-combination-with-doxorubicin-in-patients-affected-by-metastatic-small-cell-lung-carcinoma-50435https://curecurrent.com/trials/study-of-paclitaxel-carboplatin-and-pf-05212384-in-advanced-or-metastatic-nsclc-uf-sto-lung-002-50436https://curecurrent.com/trials/hazardous-surgical-smoke-risk-assessment-and-evaluation-of-a-new-smoke-extractor-system-in-the-surgical-unit-50437https://curecurrent.com/trials/a-randomized-phase-2-study-of-atezolizumab-an-engineered-anti-pdl1-antibody-compared-with-docetaxel-in-participants-with-50438https://curecurrent.com/trials/comparison-between-electronic-and-traditional-chest-drainage-systems-50439https://curecurrent.com/trials/a-study-of-sequential-anlotinib-followed-by-ep-regimen-plus-concurrent-radiotherapy-for-unresectable-stage-iii-non-small-50440https://curecurrent.com/trials/improving-goals-of-care-discussion-in-advanced-cancer-patients-50441https://curecurrent.com/trials/doxepin-hydrochloride-in-treating-esophageal-pain-in-patients-with-thoracic-cancer-receiving-radiation-therapy-to-the-th-50442https://curecurrent.com/trials/phase-i-study-of-gene-induction-mediated-by-sequential-decitabine-depsipeptide-infusion-with-or-without-concurrent-celec-50443https://curecurrent.com/trials/a-study-of-docetaxel-and-ramucirumab-versus-docetaxel-and-placebo-in-the-treatment-of-stage-iv-non-small-cell-lung-cance-50444https://curecurrent.com/trials/a-study-of-shr-1210-in-combination-with-carboplatin-paclitaxel-albumin-in-subjects-with-resectable-nsclc-50445https://curecurrent.com/trials/a-phase-2b-study-of-baricitinib-in-participants-with-moderate-to-severe-psoriasis-50446https://curecurrent.com/trials/a-study-of-rsifn-co-in-subjects-with-advanced-solid-tumors-50447https://curecurrent.com/trials/a-study-of-gemcitabine-carboplatin-plus-necitumumab-ly3012211-in-chemotherapy-na-ve-participants-with-locally-advanced-o-50448https://curecurrent.com/trials/sbrt-in-combination-with-sintilimab-and-gm-csf-for-the-treatment-of-advanced-nsclc-50449https://curecurrent.com/trials/lung-hexert-helium-xenon-mri-for-nsclc-patients-50450https://curecurrent.com/trials/multicentric-study-vats-major-introperative-complications-50451https://curecurrent.com/trials/functional-lung-avoidance-for-individualized-radiotherapy-flair-a-randomized-double-blind-clinical-trial-50452https://curecurrent.com/trials/multicentric-analysis-of-predictors-of-n1-upstaging-after-resection-of-cstage-i-nsclc-50453https://curecurrent.com/trials/a-study-of-chemotherapy-and-ramucirumab-versus-chemotherapy-alone-in-second-line-non-small-cell-lung-cancer-nsclc-partic-50454https://curecurrent.com/trials/evaluation-of-tumor-and-blood-immune-biomarkers-in-resected-non-small-cell-lung-cancer-50455https://curecurrent.com/trials/study-of-lyc-55716-with-pembrolizumab-in-adult-subjects-with-non-small-cell-lung-cancer-50456https://curecurrent.com/trials/a-study-of-pemetrexed-cisplatin-as-pre-operative-treatment-of-early-stage-nonsquamous-non-small-cell-lung-cancer-50457https://curecurrent.com/trials/adjuvant-pazopanib-in-stage-i-nsclc-50458https://curecurrent.com/trials/azacitidine-in-treating-patients-with-previously-treated-advanced-non-small-cell-lung-cancer-50459https://curecurrent.com/trials/a-study-in-participants-with-moderate-to-severe-psoriasis-50460https://curecurrent.com/trials/non-interventional-study-to-assess-the-frequency-of-cachexia-in-patients-with-non-small-cell-lung-cancer-50461https://curecurrent.com/trials/a-clinical-study-in-three-arm-of-lurbinectedin-pm01183-alone-or-in-combination-with-gemcitabine-and-a-control-arm-with-d-50462https://curecurrent.com/trials/the-fuzheng-therapy-of-tcm-to-improve-the-survival-quality-of-early-stage-nsclc-by-intervening-the-ctcs-50463https://curecurrent.com/trials/short-course-radiotherapy-followed-intensive-chemotherapy-with-delayed-surgery-for-rectal-cancer-with-synchronous-distan-50464https://curecurrent.com/trials/a-study-of-necitumumab-and-chemotherapy-in-participants-with-stage-iv-squamous-non-small-cell-lung-cancer-50465https://curecurrent.com/trials/a-study-in-non-small-cell-lung-cancer-50466https://curecurrent.com/trials/lung-cancer-diagnosis-and-staging-using-ultrasound-guidance-50467https://curecurrent.com/trials/a-phase-i-clinical-study-with-investigational-compound-ltt462-in-adult-patients-with-specific-advanced-cancers-50468https://curecurrent.com/trials/evaluation-of-appeal-and-impact-of-e-cigarettes-among-chronic-smokers-with-smoking-related-cancers-50469https://curecurrent.com/trials/trial-on-refinement-of-early-stage-lung-cancer-adjuvant-therapy-50470https://curecurrent.com/trials/a-study-in-ovarian-non-small-cell-lung-prostate-colorectal-gastroesophageal-cancers-and-squamous-cell-carcinoma-of-the-h-50471https://curecurrent.com/trials/paclitaxel-carboplatin-and-radiation-therapy-in-treating-patients-who-are-undergoing-surgery-for-stage-iii-non-small-cel-50472https://curecurrent.com/trials/a-study-of-emibetuzumab-in-non-small-cell-lung-cancer-nsclc-participants-50473https://curecurrent.com/trials/a-study-of-advanced-or-metastatic-non-small-cell-lung-cancer-50474https://curecurrent.com/trials/a-study-for-participants-with-small-cell-lung-cancer-50475https://curecurrent.com/trials/outcomes-of-surgical-resection-after-induction-treatment-in-non-small-cell-lung-cancer-srait-50476https://curecurrent.com/trials/ngr015-study-in-second-line-for-patient-with-advanced-malignant-pleural-mesothelioma-pretreated-with-pemetrexed-50477https://curecurrent.com/trials/kpt-330-to-treat-poorly-differentiated-lung-and-gastroenteropancreatic-tumors-50478https://curecurrent.com/trials/safety-and-efficacy-of-crizotinib-regulatory-post-marketing-commitment-plan-50479https://curecurrent.com/trials/a-study-of-pemetrexed-and-carboplatin-cisplatin-or-gemcitabine-and-carboplatin-cisplatin-with-or-without-imc-1121b-in-pa-50480https://curecurrent.com/trials/feasibility-study-of-a-nurse-intervention-to-impact-mucositis-severity-and-prevent-dehydration-50481https://curecurrent.com/trials/safety-and-efficiency-of-t-cell-against-non-small-lung-cancer-without-egfr-mutation-50482https://curecurrent.com/trials/combination-of-cryosurgery-and-nk-immunotherapy-for-advanced-non-small-cell-lung-cancer-50483https://curecurrent.com/trials/pembrolizumab-alone-and-in-combination-with-acalabrutinib-acp-196-in-subjects-with-advanced-non-small-cell-lung-cancer-50484https://curecurrent.com/trials/randomized-phase-iii-trial-of-surgery-alone-or-surgery-plus-preoperative-gemcitabine-cisplatin-in-early-stages-nsclc-50485https://curecurrent.com/trials/combination-of-cetuximab-and-nk-immunotherapy-for-recurrent-non-small-cell-lung-cancer-50486https://curecurrent.com/trials/high-activity-natural-killer-immunotherapy-for-small-metastases-of-non-small-cell-lung-cancer-50487https://curecurrent.com/trials/the-immunotherapy-of-nasopharyngeal-cancer-using-cancer-stem-cells-vaccine-50488https://curecurrent.com/trials/a-randomized-phase-3-trial-of-pemetrexed-and-cisplatin-versus-gemcitabine-and-cisplatin-in-patients-with-locally-advance-50489https://curecurrent.com/trials/a-comparison-of-two-doses-of-pemetrexed-in-patients-who-have-lung-cancer-50490https://curecurrent.com/trials/hsp90-inhibitor-auy922-and-erlotinib-hydrochloride-in-treating-patients-with-stage-iiib-iv-non-small-cell-lung-cancer-50491https://curecurrent.com/trials/study-of-ly2181308-in-combination-with-docetaxel-versus-docetaxel-in-patients-with-non-small-cell-lung-cancer-50492https://curecurrent.com/trials/olympus-19-gauge-needle-50493https://curecurrent.com/trials/a-study-of-pemetrexed-and-gefitinib-versus-gefitinib-in-non-small-cell-lung-cancer-nsclc-50494https://curecurrent.com/trials/expanded-access-to-rovalpituzumab-tesirine-50495https://curecurrent.com/trials/safety-efficacy-study-of-egf-cancer-vaccine-to-treat-stage-iv-biomarker-positive-wild-type-egf-r-nsclc-patients-50496https://curecurrent.com/trials/bronchoscopy-with-bronchoalveolar-lavage-in-identifying-biomarkers-of-response-to-immune-checkpoint-inhibitors-in-patien-50497https://curecurrent.com/trials/study-of-kn046-with-chemotherapy-in-first-line-advanced-nsclc-50498https://curecurrent.com/trials/study-of-nivolumab-in-combination-with-gm-cd40l-vaccine-in-adenocarcinoma-of-the-lung-50499https://curecurrent.com/trials/erlotinib-or-placebo-following-chemoradiotherapy-chemo-rt-in-stage-iii-non-small-cell-lung-cancer-nsclc-50500https://curecurrent.com/trials/microbiome-in-pulmonary-tuberculosis-non-tuberculous-mycobacterial-pulmonary-diseases-lung-cancer-and-hemoptysis-50501https://curecurrent.com/trials/photon-versus-particle-therapy-for-recurrent-lung-cancer-a-planning-study-based-on-a-reference-dataset-of-patients-50502https://curecurrent.com/trials/a-multi-center-trial-of-the-prolung-test-50503https://curecurrent.com/trials/ct-screening-for-lung-cancer-in-high-risk-patients-the-russian-study-50504https://curecurrent.com/trials/genetic-sequencing-informed-targeted-therapy-in-treating-patients-with-stage-iiib-iv-non-small-cell-lung-cancer-50505https://curecurrent.com/trials/atovaquone-as-tumour-hypoxia-modifier-50506https://curecurrent.com/trials/evolution-of-corporeal-composition-in-the-perioperative-period-50507https://curecurrent.com/trials/study-of-anlotinib-hydrochloride-capsule-in-subjects-with-small-cell-lung-cancer-50508https://curecurrent.com/trials/low-dose-computed-tomography-for-lung-cancer-screening-50509https://curecurrent.com/trials/study-of-anlotinib-hydrochloride-capsule-combined-with-chemotherapy-in-subjects-with-squamous-non-small-cell-lung-cancer-50510https://curecurrent.com/trials/to-evaluate-the-qol-improvement-of-oral-oligo-fucoidan-in-subjects-receiving-platinum-based-chemotherapy-with-nsclc-50511https://curecurrent.com/trials/a-study-to-demonstrate-the-benefit-of-a-new-kind-of-anti-cancer-treatment-preferentially-expressed-antigen-of-melanoma-p-50512https://curecurrent.com/trials/assessing-safety-and-efficacy-of-sintilimab-and-metformin-combination-therapy-in-sclc-50513https://curecurrent.com/trials/phase-3-trial-in-squamous-non-small-cell-lung-cancer-subjects-comparing-ipilimumab-plus-paclitaxel-and-carboplatin-versu-50514https://curecurrent.com/trials/liquid-biopsy-in-lung-cancer-50515https://curecurrent.com/trials/a-trial-of-amg-479-everolimus-rad001-and-panitumumab-in-patients-with-advanced-cancer-quilt-3-007-50516https://curecurrent.com/trials/prediction-model-for-multiple-pulmonary-nodules-50517https://curecurrent.com/trials/olmutinib-trial-in-t790m-nsclc-patients-detected-by-liquid-biopsy-using-balf-extracellular-vesicular-dna-50518https://curecurrent.com/trials/understanding-evidence-based-practice-patterns-in-advanced-nsclc-50519https://curecurrent.com/trials/identifying-genomic-mutations-of-multiple-primary-lung-cancers-by-circulating-tumor-dna-50520https://curecurrent.com/trials/18-f-faza-pet-imaging-study-in-patients-with-cancer-of-the-head-neck-lung-renal-cell-brain-lymphoma-and-neuroendocrine-t-50521https://curecurrent.com/trials/real-world-study-on-adjuvant-therapy-combined-with-shenlingcao-oral-liquid-in-patients-for-stage-ii-and-iiia-non-small-c-50522https://curecurrent.com/trials/cisplatin-irinotecan-with-concurrent-radiation-for-inoperable-nsclc-50523https://curecurrent.com/trials/effect-of-magnesium-sulphate-infusion-on-lung-mechanics-and-oxygenation-in-copd-patients-undergoing-total-laryngeal-50524https://curecurrent.com/trials/detection-of-circulating-biomarkers-of-immunogenic-cell-death-50525https://curecurrent.com/trials/study-of-anlotinib-combined-with-osimertinib-as-second-line-treatment-in-stage-iiib-iv-nsclc-with-confirmed-egfrm-and-t7-50526https://curecurrent.com/trials/endostar-pd-1-inhibitors-combined-with-pp-for-advanced-nsclc-50527https://curecurrent.com/trials/pulmonary-nodule-detection-comparison-of-an-ultra-low-dose-vs-standard-scan-50528https://curecurrent.com/trials/phase-2-study-of-pyrotinib-in-previously-treated-patients-with-nsclc-having-egfr-or-erbb2-exon-20-insertion-mutation-50529https://curecurrent.com/trials/curative-proton-beam-therapy-for-patients-with-lung-metastasis-of-colorectal-cancer-50530https://curecurrent.com/trials/treating-nsclc-minimal-stage-iv-with-curative-intent-50531https://curecurrent.com/trials/evaluation-of-the-impact-of-a-coordinating-nurse-in-a-personalized-care-program-on-quality-of-care-coordination-of-the-a-50532https://curecurrent.com/trials/study-to-evaluate-gsk3052230-in-combination-with-paclitaxel-and-carboplatin-or-docetaxel-or-as-single-agent-in-subjects-50533https://curecurrent.com/trials/dynamic-magnetic-resonance-imaging-mri-for-lung-tumor-motion-and-lung-function-gcc-0943-50534https://curecurrent.com/trials/treatment-of-non-small-cell-lung-cancer-with-pd-1-monoclonal-antibody-combined-with-donafenib-toluene-sulfonate-50535https://curecurrent.com/trials/effect-of-qigong-therapy-in-patients-with-advanced-lung-and-gastrointestinal-cancer-undergoing-chemotherapy-50536https://curecurrent.com/trials/safety-and-efficacy-study-of-tq-b3101-in-patients-with-ros1-positive-non-small-cell-lung-cancer-nsclc-50537https://curecurrent.com/trials/study-of-tqb2450-combined-with-anlotinib-in-the-treatment-of-mutation-positive-lung-cancer-50538https://curecurrent.com/trials/a-study-to-determine-the-efficiency-for-brain-metastasis-nsclc-patients-treated-with-icotinib-alone-or-combined-with-rad-50539https://curecurrent.com/trials/measure-of-plasma-tissue-factor-to-predict-a-venous-thromboembolism-in-primitive-cancer-of-lung-50540https://curecurrent.com/trials/can-a-pulmonologist-reliably-assess-the-tumor-burden-on-rose-slides-obtained-from-pulmonary-nodules-and-lymphadenopathy-50541https://curecurrent.com/trials/efficacy-and-safety-of-ibi308-and-paclitaxel-albumin-paclitaxel-for-sclc-patients-who-failed-etoposide-chemotherapy-50542https://curecurrent.com/trials/3d-printing-for-nodule-localization-50543https://curecurrent.com/trials/tiger-3-open-label-multicenter-study-of-rociletinib-co-1686-mono-therapy-versus-single-agent-cytotoxic-chemotherapy-in-p-50544https://curecurrent.com/trials/the-safety-and-efficacy-of-pemetrexed-rechallenge-with-bevacizumab-50545https://curecurrent.com/trials/study-of-the-safety-and-activity-of-lenvatinib-e7080-in-subjects-with-kif5b-ret-positive-adenocarcinoma-of-the-lung-50546https://curecurrent.com/trials/oncolytic-adenovirus-mediated-gene-therapy-for-lung-cancer-50547https://curecurrent.com/trials/afatinib-bibw-2992-in-advanced-non-small-cell-lung-cancer-patients-with-egfr-mutation-50548https://curecurrent.com/trials/reducing-insulin-growth-hormones-and-tumors-50549https://curecurrent.com/trials/study-of-bms-986012-in-subjects-with-small-cell-lung-caner-50550https://curecurrent.com/trials/evaluation-of-a-multi-professional-breathlessness-service-for-patients-with-breathlessness-due-to-any-advanced-disease-50551https://curecurrent.com/trials/prospective-study-on-the-treatment-of-unsuspected-pulmonary-embolism-in-cancer-patients-50552https://curecurrent.com/trials/pulmonary-nodule-cohort-50553https://curecurrent.com/trials/prospective-analysis-of-robot-assisted-surgery-50554https://curecurrent.com/trials/real-world-data-on-gi-l-otrif-dose-adjustment-50555https://curecurrent.com/trials/risk-adapted-sabr-sabr-in-stage-i-nsclc-and-lung-metastases-50556https://curecurrent.com/trials/phase-2-study-of-inhaled-lipid-cisplatin-in-pulmonary-recurrent-osteosarcoma-50557https://curecurrent.com/trials/erlotinib-hydrochloride-with-or-without-carboplatin-and-paclitaxel-in-treating-patients-with-stage-iii-iv-non-small-cell-50558https://curecurrent.com/trials/re-directed-t-cells-for-the-treatment-fap-positive-malignant-pleural-mesothelioma-50559https://curecurrent.com/trials/a-study-of-trastuzumab-emtansine-in-participants-with-human-epidermal-growth-factor-receptor-her-2-immunohistochemistry-50560https://curecurrent.com/trials/combination-immunotherapy-of-gm-cd40l-vaccine-with-ccl21-in-lung-cancer-50561https://curecurrent.com/trials/circulating-dna-in-surgically-treated-nsclc-50562https://curecurrent.com/trials/erlotinib-hydrochloride-or-crizotinib-and-chemoradiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-50563https://curecurrent.com/trials/consolidation-treatment-with-ponatinib-15-mg-on-treatment-free-remission-rate-in-patients-with-chronic-myeloid-leukemia-50564https://curecurrent.com/trials/the-efficacy-of-pd-1-antibody-sintilimab-on-early-stage-multiple-primary-lung-cancer-with-ground-glass-density-50565https://curecurrent.com/trials/evaluate-egfr-mutation-status-and-impact-factors-in-north-china-50566https://curecurrent.com/trials/immune-modulated-study-of-selected-small-molecules-gefitinib-azd9291-or-selumetinib-docetaxel-or-a-1st-immune-mediated-t-50567https://curecurrent.com/trials/palliative-thoracic-radiotherapy-plus-bkm120-50568https://curecurrent.com/trials/a-real-world-study-to-explore-recurrence-metastases-of-the-nsclc-patients-and-the-impact-factors-of-patient-survivals-50569https://curecurrent.com/trials/the-affection-of-two-chest-management-for-enhanced-recovery-program-after-video-assisted-thoracoscopic-lobectomy-50570https://curecurrent.com/trials/a-phase-i-ii-trial-of-stereotactic-body-radiation-therapy-50571https://curecurrent.com/trials/cancer-development-in-organ-transplant-recipients-50572https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-the-vegfr-fgfr-inhibitor-lucitanib-given-to-patients-with-advanced-metastat-50573https://curecurrent.com/trials/clinical-and-pathophysiological-investigations-into-erdheim-chester-disease-50574https://curecurrent.com/trials/a-study-to-investigate-the-food-effect-on-the-pharmacokinetics-of-ensartinib-capsules-in-chinese-healthy-volunteers-50575https://curecurrent.com/trials/bioequivalency-study-of-ensartinib-capsules-in-healthy-volunteers-50576https://curecurrent.com/trials/an-open-label-randomized-phase-ii-study-to-evaluate-the-efficacy-of-auy922-vs-pemetrexed-or-docetaxel-in-nsclc-patients-50577https://curecurrent.com/trials/an-observational-post-authorisation-study-to-evaluate-safety-and-efficacy-in-patients-receiving-azacitidine-in-daily-cli-50578https://curecurrent.com/trials/acupuncture-feasibility-trial-for-dyspnea-in-lung-cancer-50579https://curecurrent.com/trials/evaluation-of-use-of-diagnostic-ai-for-lung-cancer-in-practice-50580https://curecurrent.com/trials/a-study-to-assess-programmed-death-ligand-1-pd-l1-expression-in-cytological-versus-histological-lung-cancer-specimens-50581https://curecurrent.com/trials/a-study-of-ly2510924-in-participants-with-extensive-stage-small-cell-lung-carcinoma-50582https://curecurrent.com/trials/phase-i-study-of-tetrathiomolybdate-in-combination-with-carboplatin-pemetrexed-in-metastatic-non-small-cell-lung-cancer-50583https://curecurrent.com/trials/retrospective-epidemiology-study-of-alk-rearrangement-in-non-small-cell-lung-cancer-patients-in-the-middle-east-north-af-50584https://curecurrent.com/trials/genomic-landscape-of-egfr-mutant-nsclc-prior-to-erlotinib-and-at-the-time-of-disease-progression-50585https://curecurrent.com/trials/inhaled-steroids-for-pediatric-asthma-at-pediatric-emergency-medicine-discharge-50586https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetic-profile-of-bpi-15086-in-egfr-t790m-mutation-positive-nsclc-patients-50587https://curecurrent.com/trials/a-study-of-nivolumab-docetaxel-in-patients-previously-treated-with-advanced-or-metastatic-nsclc-50588https://curecurrent.com/trials/quantification-of-micrornas-in-diagnosis-of-pulmonary-nodules-50589https://curecurrent.com/trials/study-of-glembatumumab-vedotin-in-gpnmb-expressing-advanced-or-metastatic-scc-of-the-lung-50590https://curecurrent.com/trials/19f-thoracic-radiotherapy-for-lung-cancer-50591https://curecurrent.com/trials/mechanically-assisted-ventilation-in-the-treatment-of-moving-tumours-with-photon-and-proton-therapies-50592https://curecurrent.com/trials/a-study-to-determine-the-feasibility-and-acceptability-of-conducting-a-phase-iii-randomised-controlled-trial-comparing-s-50593https://curecurrent.com/trials/early-palliative-care-in-metastatic-lung-cancer-in-northern-france-50594https://curecurrent.com/trials/magnetic-resonance-imaging-mri-for-the-delineation-of-organs-at-risk-oar-and-target-volumes-in-lung-cancer-patients-50595https://curecurrent.com/trials/haploidentical-nk-cells-after-pemetrexed-in-patients-with-stage-iv-non-small-cell-lung-cancer-nsclc-50596https://curecurrent.com/trials/exercise-intervention-during-chemotherapy-in-advanced-lung-cancer-patients-50597https://curecurrent.com/trials/wholebody-mri-in-lung-cancer-staging-50598https://curecurrent.com/trials/anlotinib-hydrochloride-combined-with-egfr-tyrosine-kinase-inhibitor-tki-in-treating-advanced-nsclc-patients-with-acquir-50599https://curecurrent.com/trials/inflammatory-response-after-one-lung-ventilation-according-to-ventilation-methods-50600https://curecurrent.com/trials/inpatient-smokers-and-ldct-screening-rct-50601https://curecurrent.com/trials/effect-of-dexmedetomidine-on-the-inflammatory-response-after-one-lung-ventilation-50602https://curecurrent.com/trials/a-phase-1b-2-study-of-safety-and-efficacy-of-rociletinib-in-combination-with-mpdl3280a-in-patients-with-advanced-or-meta-50603https://curecurrent.com/trials/overall-survival-of-large-cell-neuroendocrine-lung-cancer-patients-a-retrospective-study-50604https://curecurrent.com/trials/physical-impairments-related-to-myeloid-and-lymphoid-malignancies-50605https://curecurrent.com/trials/crizotinib-plus-pembrolizumab-in-alk-positive-advanced-non-small-cell-lung-cancer-patients-50606https://curecurrent.com/trials/combined-cfrt-and-sabr-in-stage-ii-and-iii-nsclc-with-peripheral-tumors-smaller-than-5-cm-50607https://curecurrent.com/trials/irradiation-of-large-lung-tumors-or-two-or-more-lung-metastases-simultaneously-50608https://curecurrent.com/trials/alisertib-mln8237-in-combination-with-weekly-paclitaxel-in-east-asian-patients-with-advanced-solid-tumors-50609https://curecurrent.com/trials/effects-of-vns-on-rt-induced-inflammation-and-prognosis-of-patients-with-nsclc-50610https://curecurrent.com/trials/bortezomib-ps-341-in-combination-with-carboplatin-and-docetaxel-for-patients-with-advanced-non-small-cell-lung-cancer-50611https://curecurrent.com/trials/comparison-of-iv-topotecan-docetaxel-to-docetaxel-alone-in-second-line-stage-iiib-iv-non-small-cell-lung-cancer-50612https://curecurrent.com/trials/clinical-study-of-combination-therapy-with-ectiecinib-pemetrexed-and-platinum-in-patients-with-metastatic-non-squamous-n-50613https://curecurrent.com/trials/expression-analysis-of-specific-markers-in-non-small-cell-lung-cancer-or-melanoma-50614https://curecurrent.com/trials/methods-of-computed-tomography-screening-and-management-of-lung-cancer-50615https://curecurrent.com/trials/efficacy-study-of-vx001-vaccine-in-nsclc-patients-50616https://curecurrent.com/trials/computed-tomography-screening-for-early-lung-cancer-copd-and-cardiovascular-disease-in-shanghai-china-50617https://curecurrent.com/trials/study-of-chemotherapy-combination-with-autologous-cell-immunotherapy-in-the-advanced-lung-cancer-50618https://curecurrent.com/trials/a-randomized-study-of-primary-tumor-radiotherapy-for-patients-with-mpe-stage-iv-nsclc-50619https://curecurrent.com/trials/malignant-mesothelioma-can-we-improve-quality-of-life-50620https://curecurrent.com/trials/nivolumab-and-epacadostat-with-platinum-doublet-chemotherapy-versus-platinum-doublet-chemotherapy-in-non-small-cell-lung-50621https://curecurrent.com/trials/efficacy-study-of-comprehensive-rehabilitation-program-plus-chemotherapy-in-postoperative-nsclc-patients-50622https://curecurrent.com/trials/evaluation-in-real-world-of-molecular-testing-and-treatment-patterns-for-egfr-mutation-in-lung-cancer-patients-50623https://curecurrent.com/trials/efficacy-study-of-comprehensive-rehabilitation-program-in-postoperative-nsclc-patients-50624https://curecurrent.com/trials/adjuvant-chemotherapy-with-or-without-intercalated-icotinib-50625https://curecurrent.com/trials/pathos-study-pain-assessment-in-thoracic-oncologic-surgery-50626https://curecurrent.com/trials/anlotinib-combined-with-docetaxel-versus-docetaxel-for-previous-treated-advanced-nsclc-50627https://curecurrent.com/trials/ss1p-and-pentostatin-plus-cyclophosphamide-for-mesothelioma-50628https://curecurrent.com/trials/oncoxin-and-quality-of-life-in-cancer-patients-50629https://curecurrent.com/trials/study-of-thalidomide-in-treatment-of-advanced-nsclc-dream-003-50630https://curecurrent.com/trials/cbct-in-guiding-bronchoscopy-in-patients-with-lung-lesions-50631https://curecurrent.com/trials/comparison-of-diagnostic-and-therapeutic-efficacy-of-ebus-tbna-eus-fna-and-temla-in-operable-nsclc-50632https://curecurrent.com/trials/the-role-of-microbiota-on-the-development-of-lung-cancer-50633https://curecurrent.com/trials/pd-1-inhibitors-consolidation-in-extensive-stage-small-cell-lung-cancer-50634https://curecurrent.com/trials/gene-polymorphisms-and-symptoms-in-lung-cancer-patients-50635https://curecurrent.com/trials/carboplatin-pemetrexed-disodium-and-bevacizumab-in-treating-patients-with-stage-iiib-stage-iv-or-recurrent-non-small-cel-50636https://curecurrent.com/trials/low-dose-protocol-for-computed-tomography-guided-lung-biopsy-50637https://curecurrent.com/trials/neck-ultrasound-by-respiratory-physicians-in-patients-with-lung-cancer-50638https://curecurrent.com/trials/pneumoperitoneum-management-with-low-vs-higher-pressure-50639https://curecurrent.com/trials/folate-one-carbon-malnutrition-as-the-metabostemness-risk-factor-of-malignancy-tumor-development-of-nsclc-patients-50640https://curecurrent.com/trials/g-csf-and-pegfilgrastim-in-treating-neutropenia-in-patients-undergoing-radiation-therapy-and-chemotherapy-for-limited-st-50641https://curecurrent.com/trials/ifct-gfpc-05-02-a-randomized-phase-iii-trial-assessing-in-patients-with-advanced-non-small-cell-lung-cancer-50642https://curecurrent.com/trials/three-modalities-of-treatment-in-operable-and-resectable-stage-iiia-t1-3-n2-non-small-cell-lung-cancer-nsclc-50643https://curecurrent.com/trials/an-observational-study-of-cpt-11-plus-platinum-analogues-regimens-and-ugt1a1-genotypes-in-solid-tumors-50644https://curecurrent.com/trials/nm404-as-an-imaging-agent-in-patients-with-nsclc-50645https://curecurrent.com/trials/anti-mesothelin-antibody-drug-conjugate-anetumab-ravtansine-for-mesothelin-expressing-lung-adenocarcinoma-50646https://curecurrent.com/trials/nse-alb-as-a-prognostic-biomarker-for-lung-cancer-50647https://curecurrent.com/trials/pf-00299804-as-a-single-agent-in-patients-with-advanced-non-small-cell-lung-cancer-who-have-failed-chemotherapy-and-erlo-50648https://curecurrent.com/trials/ct-guided-radioactive-i-125-seeds-implantation-for-early-stage-lung-cancer-50649https://curecurrent.com/trials/nivolumab-in-treating-patients-with-advanced-metastatic-non-small-cell-lung-cancer-50650https://curecurrent.com/trials/clinical-significance-of-computer-aided-image-analysis-in-treatment-response-evaluation-of-lung-cancer-50651https://curecurrent.com/trials/concordance-of-inivata-liquid-biopsy-with-standard-of-care-tissue-testing-50652https://curecurrent.com/trials/cabozantinib-s-malate-and-erlotinib-hydrochloride-in-treating-patients-with-previously-treated-metastatic-non-small-cell-50653https://curecurrent.com/trials/concordance-of-inivata-liquid-biopsy-with-standard-tissue-biopsy-50654https://curecurrent.com/trials/study-of-anlotinib-in-patients-with-small-cell-lung-cancer-alter1202-50655https://curecurrent.com/trials/bevacizumab-and-erlotinib-followed-by-cisplatin-or-carboplatin-and-gemcitabine-in-treating-patients-with-newly-diagnosed-50656https://curecurrent.com/trials/six-minute-walk-test-in-patients-at-high-risk-for-complications-from-lung-resection-50657https://curecurrent.com/trials/bevacizumab-pemetrexed-disodium-and-cisplatin-or-erlotinib-hydrochloride-and-bevacizumab-in-treating-patients-with-stage-50658https://curecurrent.com/trials/pemetrexed-disodium-and-cisplatin-followed-by-surgery-with-or-without-radiation-therapy-in-treating-patients-with-malign-50659https://curecurrent.com/trials/battle-fl-front-line-biomarker-integrated-treatment-study-in-non-small-cell-lung-cancer-50660https://curecurrent.com/trials/k-ras-and-egfr-in-lung-cancer-50661https://curecurrent.com/trials/combination-chemotherapy-followed-by-surgery-in-treating-patients-with-non-small-cell-lung-cancer-50662https://curecurrent.com/trials/combination-chemotherapy-followed-by-radiation-therapy-before-surgery-in-treating-patients-with-stage-iiib-nsclc-50663https://curecurrent.com/trials/dexamethasone-for-treatment-of-radiation-related-fatigue-in-patients-receiving-rt-for-head-neck-and-lung-cancer-50664https://curecurrent.com/trials/the-wessex-fit-4-cancer-surgery-trial-50665https://curecurrent.com/trials/azacitidine-and-entinostat-in-treating-patients-with-recurrent-advanced-non-small-cell-lung-cancer-50666https://curecurrent.com/trials/radiofrequency-ablation-and-external-beam-radiation-therapy-in-treating-patients-with-stage-i-non-small-cell-lung-cancer-50667https://curecurrent.com/trials/efficacy-and-safety-of-omega-3-fatty-acid-supplements-on-heavy-smokers-50668https://curecurrent.com/trials/erector-spinae-plane-block-for-postoperative-analgesia-management-following-video-assisted-thoracic-surgery-50669https://curecurrent.com/trials/exemestane-pemetrexed-disodium-and-carboplatin-in-treating-post-menopausal-women-with-stage-iv-non-small-cell-lung-cance-50670https://curecurrent.com/trials/anlotinib-therapy-in-patients-with-advanced-lung-cancer-50671https://curecurrent.com/trials/tiger-1-safety-and-efficacy-study-of-rociletinib-co-1686-or-erlotinib-in-patients-with-egfr-mutant-metastatic-nsclc-who-50672https://curecurrent.com/trials/assessment-of-patient-frailty-prior-to-thoracic-surgery-50673https://curecurrent.com/trials/18fdg-pet-in-patients-with-melanoma-or-nsclc-treated-with-immunotherapy-50674https://curecurrent.com/trials/zoledronic-acid-in-decrease-the-lung-metastatic-rate-of-osteosarcoma-50675https://curecurrent.com/trials/self-management-intervention-for-breathlessness-in-lung-cancer-50676https://curecurrent.com/trials/stereotactic-body-radiotherapy-and-radiofrequency-ablation-for-lung-tumors-near-central-airways-50677https://curecurrent.com/trials/evaluating-mutations-in-met-and-tp53-among-patients-diagnosed-with-squamous-cell-carcinoma-50678https://curecurrent.com/trials/the-effect-of-iloprost-on-oxygenation-during-one-lung-ventilation-for-lung-surgery-50679https://curecurrent.com/trials/a-phase-i-dose-escalation-study-of-erlotinib-in-combination-with-theophylline-50680https://curecurrent.com/trials/pet-ct-directed-hyperfractionated-radiation-dose-escalation-in-stage-iii-non-small-cell-lung-cancer-50681https://curecurrent.com/trials/microarray-analysis-of-gene-expression-and-identification-of-progenitor-cells-in-lung-carcinoma-50682https://curecurrent.com/trials/pemetrexed-disodium-and-gemcitabine-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-50683https://curecurrent.com/trials/efficacy-study-of-long-term-parenteral-nutrition-with-smofkabiven-e-in-lung-cancer-patients-under-anticancer-therapy-50684https://curecurrent.com/trials/stereotactic-body-radiation-therapy-in-treating-patients-with-stage-i-or-stage-ii-non-small-cell-lung-cancer-that-can-be-50685https://curecurrent.com/trials/docetaxel-versus-intercalated-erlotinib-docetaxel-in-patients-with-relapsed-egfr-wild-type-alk-negative-non-squamous-cel-50686https://curecurrent.com/trials/the-attain-study-a-therapeutic-trial-of-afatinib-in-the-neoadjuvant-setting-50687https://curecurrent.com/trials/efficacy-of-flutiform-vs-seretide-in-moderate-to-severe-persistent-asthma-in-subjects-aged-12-years-50688https://curecurrent.com/trials/role-of-spect-in-radiotherapy-of-lung-cancer-and-toxicity-evaluation-50689https://curecurrent.com/trials/oral-immunomodulatory-tyrosine-kinase-inhibitor-in-patients-with-locally-advanced-or-metastatic-solid-tumors-50690https://curecurrent.com/trials/study-of-rxdx-105-potent-ret-inhibitor-in-patients-with-advanced-lung-cancer-and-other-solid-tumors-50691https://curecurrent.com/trials/monitoring-and-telecoaching-of-physical-activity-in-patients-with-stage-iii-and-iv-non-small-cell-lung-cancer-50692https://curecurrent.com/trials/pazopanib-in-patients-with-relapsed-or-refractory-small-cell-lung-cancer-50693https://curecurrent.com/trials/maintenance-low-dose-oral-navelbine-in-patients-with-non-small-cell-lung-cancer-ma-ni-la-trial-50694https://curecurrent.com/trials/immune-checkpoint-inhibitors-and-pre-existing-autoimmune-diseases-50695https://curecurrent.com/trials/biomarker-study-accompanying-the-aio-trk-0114-study-marble-50696https://curecurrent.com/trials/impact-of-smoking-information-on-concerns-about-radon-50697https://curecurrent.com/trials/a-study-of-dabigatran-etexilate-as-primary-treatment-of-malignancy-associated-venous-thromboembolism-50698https://curecurrent.com/trials/tki-followed-by-thoracic-radiotherapy-for-stage-iv-egfr-mutant-nsclc-50699https://curecurrent.com/trials/atezolizumab-in-combination-with-bevacizumab-carboplatin-and-pemetrexed-for-egfr-mutant-metastatic-nsclc-patients-after-50700https://curecurrent.com/trials/hs-pci-in-locally-advanced-adenocarcinoma-of-the-lung-50701https://curecurrent.com/trials/a-series-of-study-in-testing-efficacy-of-pulmonary-rehabilitation-interventions-in-lung-cancer-survivors-50702https://curecurrent.com/trials/study-of-autologous-tumor-infiltrating-lymphocytes-ln-145-in-combo-with-durvalumab-in-non-small-cell-lung-cancer-50703https://curecurrent.com/trials/effectiveness-of-bronchoscopic-interventions-for-malignant-airway-obstruction-50704https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-cp-690-550-in-asian-subjects-with-moderate-to-severe-plaque-psoriasis-50705https://curecurrent.com/trials/study-of-hsp90-inhibitor-sta-9090-for-relapsed-or-refractory-small-cell-lung-cancer-50706https://curecurrent.com/trials/clinical-study-of-chinese-medicine-plus-chemotherapy-maintenance-in-advanced-non-small-cell-lung-cancer-50707https://curecurrent.com/trials/immunization-of-patients-with-non-small-cell-lung-cancer-nsclc-50708https://curecurrent.com/trials/imrt-combined-with-erlotinib-for-egfr-wild-type-non-small-cell-lung-cancer-with-4-10-brain-metastases-50709https://curecurrent.com/trials/perfusion-induced-hyperthermia-for-metastatic-carcinoma-50710https://curecurrent.com/trials/personalized-therapeutic-anti-tumor-vaccine-with-pembrolizumab-and-standard-of-care-chemotherapy-in-squamous-non-small-c-50711https://curecurrent.com/trials/pioglitazone-for-lung-cancer-chemoprevention-50712https://curecurrent.com/trials/clinical-study-of-chinese-medicine-plus-targeted-therapy-maintenance-in-advanced-pulmonary-adenocarcinoma-50713https://curecurrent.com/trials/clinical-study-of-yyjd-decoction-combined-with-gefitinib-in-advanced-pulmonary-adenocarcinoma-50714https://curecurrent.com/trials/cabozantinib-in-non-small-cell-lung-cancer-nsclc-patients-with-met-deregulation-50715https://curecurrent.com/trials/in-hospital-physiotherapy-for-patients-undergoing-thoracic-surgery-a-randomized-controlled-trial-50716https://curecurrent.com/trials/care-coordination-in-oncology-quality-among-patients-with-lung-cancer-and-their-caregivers-50717https://curecurrent.com/trials/move-for-surgery-mfs-evaluating-the-use-of-wearable-technology-for-preconditioning-before-thoracic-surgery-50718https://curecurrent.com/trials/bevacizumab-and-radiotherapy-for-oligometastasis-of-lung-adenocarcinoma-with-negative-driver-gene-50719https://curecurrent.com/trials/oral-green-tea-extract-for-small-cell-lung-cancer-50720https://curecurrent.com/trials/pet-ct-based-radiomics-for-lung-cancer-perl-50721https://curecurrent.com/trials/comparable-study-of-different-thoracic-radiotherapy-regimens-for-extensive-stage-small-cell-lung-cancer-50722https://curecurrent.com/trials/apatinib-combined-with-egfr-tki-for-advanced-slow-progressed-egfr-tki-resistant-nsclc-50723https://curecurrent.com/trials/a-study-of-anti-pd1-antibody-activated-tils-in-non-small-cell-lung-cancer-50724https://curecurrent.com/trials/awake-thoracic-epidural-anaesthesia-versus-general-anesthesia-for-video-assisted-thoracoscopic-surgery-50725https://curecurrent.com/trials/evaluation-of-crs-207-with-pembrolizumab-in-previously-treated-malignant-pleural-mesothelioma-mpm-50726https://curecurrent.com/trials/development-and-feasibility-testing-of-a-lung-cancer-screening-decision-aid-50727https://curecurrent.com/trials/canpos-predictive-biomarkers-of-tumor-progression-in-non-small-cell-lung-cancer-50728https://curecurrent.com/trials/the-impact-of-intraoperative-systemic-lidocaine-infusion-on-chronic-postoperative-pain-after-video-assisted-thoracic-sur-50729https://curecurrent.com/trials/intrapleural-bevacizumab-injection-for-malignant-effusion-in-lung-cancer-50730https://curecurrent.com/trials/phase-i-study-of-the-combination-of-afatinib-and-ruxolitinib-in-patients-with-treatment-refractory-non-small-cell-lung-c-50731https://curecurrent.com/trials/eicosanoid-lipids-by-airway-cells-during-infection-with-human-rhinoviruses-50732https://curecurrent.com/trials/temozolomide-in-preventing-brain-metastases-in-small-cell-lung-cancer-50733https://curecurrent.com/trials/screening-for-lung-cancer-in-the-hiv-patient-50734https://curecurrent.com/trials/anlotinib-combined-with-etoposide-and-platinum-in-the-treatment-of-lung-cancer-50735https://curecurrent.com/trials/pemetrexed-cisplatin-intercalating-gefitinib-treating-egfr-wild-nsclc-50736https://curecurrent.com/trials/effects-of-intraoperative-continuous-airway-pressure-cpap-on-the-inflammatory-response-to-one-lung-ventilation-50737https://curecurrent.com/trials/bevacizumab-and-docetaxel-in-treating-older-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-cancer-50738https://curecurrent.com/trials/clinical-study-of-first-line-treatment-of-small-cell-lung-cancer-sclc-with-anlotinib-hydrochloride-50739https://curecurrent.com/trials/vandetanib-carboplatin-and-paclitaxel-in-treating-patients-with-stage-i-stage-ii-or-stage-iii-non-small-cell-lung-cancer-50740https://curecurrent.com/trials/abscopal-effect-for-metastatic-non-small-cell-lung-cancer-50741https://curecurrent.com/trials/a-phase-i-iia-open-label-dose-escalation-and-cohort-expansion-trial-of-oral-tsr-011-in-patients-with-advanced-solid-tumo-50742https://curecurrent.com/trials/prevention-of-locally-advanced-nsclc-radiotherapy-pneumonia-by-inhaling-beclomethasone-propionate-50743https://curecurrent.com/trials/ldk378-in-crizotinib-na-ve-adult-patients-with-alk-activated-non-small-cell-lung-cancer-50744https://curecurrent.com/trials/sdc-for-lung-cancer-patients-treated-with-curative-primary-or-postoperative-radiotherapy-or-chemoradiation-50745https://curecurrent.com/trials/bnp-for-prediction-of-outcome-following-lung-resection-surgery-50746https://curecurrent.com/trials/evaluation-of-endobronchial-ultrasound-ebus-for-staging-lung-cancer-50747https://curecurrent.com/trials/photodynamic-therapy-during-surgery-in-treating-patients-with-pleural-malignancy-50748https://curecurrent.com/trials/consolidation-sintilimab-after-concurrent-chemoradiation-in-patients-with-unresectable-stage-iii-nsclc-50749https://curecurrent.com/trials/abscopal-effect-for-metastatic-small-cell-lung-cancer-50750https://curecurrent.com/trials/improving-communication-about-serious-illness-50751https://curecurrent.com/trials/carboplatin-bevacizumab-and-pemetrexed-in-advanced-non-small-cell-lung-cancer-50752https://curecurrent.com/trials/safety-and-efficacy-study-of-epitope-peptide-to-treat-hla-a-24-disease-controlled-advanced-non-small-cell-lung-cancer-50753https://curecurrent.com/trials/intrathecal-pemetrexed-for-recurrent-leptomeningeal-metastases-from-non-small-cell-lung-cancer-50754https://curecurrent.com/trials/safety-study-of-peptide-cancer-vaccine-to-treat-hla-a-02-positive-advanced-non-small-cell-lung-cancer-50755https://curecurrent.com/trials/safety-and-efficacy-study-of-epitope-peptide-to-treat-hla-a-02-disease-controlled-advanced-non-small-cell-lung-cancer-50756https://curecurrent.com/trials/sintilimab-combined-with-metformin-in-first-line-chemotherapy-refractory-advanced-nsclc-patients-50757https://curecurrent.com/trials/safety-study-of-peptide-cancer-vaccine-to-treat-hla-a-24-positive-advanced-non-small-cell-lung-cancer-50758https://curecurrent.com/trials/safety-study-of-peptide-cancer-vaccine-to-treat-hla-a-24-positive-advanced-small-cell-lung-cancer-50759https://curecurrent.com/trials/a-dose-escalation-expansion-study-of-ldk378-in-patients-with-tumors-characterized-by-genetic-abnormalities-in-anaplastic-50760https://curecurrent.com/trials/an-expanded-access-programme-with-iressa-for-patients-with-non-small-cell-lung-cancer-and-cancer-of-the-head-and-neck-50761https://curecurrent.com/trials/investigation-of-the-effect-of-nintedanib-on-the-pharmacokinetics-of-a-combination-of-ethinylestradiol-and-levonorgestre-50762https://curecurrent.com/trials/lung-cancer-registry-for-lung-cancer-patients-50763https://curecurrent.com/trials/a-phase-i-ii-open-label-non-randomized-dose-escalation-study-of-immunoconjugate-l-dos47-50764https://curecurrent.com/trials/tissue-microarrays-tmas-construction-in-lung-cancer-samples-50765https://curecurrent.com/trials/radiomics-multifactorial-biomarker-for-pulmonary-nodules-50766https://curecurrent.com/trials/whole-brain-radiation-with-or-without-erlotinib-for-brain-metastases-from-non-small-cell-lung-cancer-50767https://curecurrent.com/trials/tipifarnib-plus-radiation-therapy-after-combination-chemotherapy-in-treating-patients-with-stage-iii-non-small-cell-lung-50768https://curecurrent.com/trials/pilot-study-to-evaluate-optical-frequency-domain-imaging-for-diagnosis-of-central-airway-disease-50769https://curecurrent.com/trials/neoantigen-primed-dc-vaccines-therapy-for-refractory-lung-cancer-50770https://curecurrent.com/trials/image-guided-functional-lung-avoidance-thoracic-radiotherapy-for-lung-cancer-a-single-blind-randomized-trial-50771https://curecurrent.com/trials/outcome-of-cisplatin-and-vinblastine-versus-paclitaxel-and-carboplatin-as-sequential-chemotherapy-followed-by-radiothera-50772https://curecurrent.com/trials/20k-distributed-learning-challenge-50773https://curecurrent.com/trials/itacitinib-in-combination-with-erlotinib-in-non-small-cell-lung-cancer-patients-with-epidermal-growth-factor-receptor-eg-50774https://curecurrent.com/trials/study-of-stepped-palliative-care-in-patients-with-advanced-lung-cancer-df-hcc-social-behavioral-reserach-protocol-50775https://curecurrent.com/trials/intrapleural-docetaxel-administration-using-medical-pleuroscopy-in-malignant-effusion-with-lung-cancer-50776https://curecurrent.com/trials/radiofrequency-ablation-in-resectable-colorectal-lung-metastasis-50777https://curecurrent.com/trials/trial-of-erlotinib-and-bkm120-in-patients-with-advanced-non-small-cell-lung-cancer-previously-sensitive-to-erlotinib-50778https://curecurrent.com/trials/cancer-venous-thromboembolism-vte-50779https://curecurrent.com/trials/sorafenib-in-treating-non-smokers-or-former-light-smokers-with-relapsed-or-refractory-stage-iiib-or-stage-iv-non-small-c-50780https://curecurrent.com/trials/phase-1-study-of-intradermal-lv305-in-patients-with-locally-advanced-relapsed-or-metastatic-cancer-expressing-ny-eso-1-50781https://curecurrent.com/trials/a-study-of-paclitaxel-and-carboplatin-in-combination-with-bexarotene-oral-capsules-in-patients-with-advanced-lung-cancer-50782https://curecurrent.com/trials/dexamethasone-flurbiprofen-axetil-and-long-term-survival-after-lung-cancer-surgery-50783https://curecurrent.com/trials/a-feasibility-study-of-unsupervised-pre-operative-exercise-program-for-patients-scheduled-for-lung-cancer-surgery-50784https://curecurrent.com/trials/dasatinib-in-treating-patients-with-stage-iiib-stage-iv-or-recurrent-non-small-cell-lung-cancer-50785https://curecurrent.com/trials/erlotinib-with-or-without-fulvestrant-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-50786https://curecurrent.com/trials/nivolumab-and-plinabulin-in-treating-patients-with-stage-iiib-iv-recurrent-or-metastatic-non-small-cell-lung-cancer-50787https://curecurrent.com/trials/evaluation-of-the-impact-of-nurse-led-telephone-on-treatment-compliance-50788https://curecurrent.com/trials/abivertinib-maleate-versus-geifitinib-in-patients-with-advanced-non-small-cell-lung-cancer-with-sensitive-egfr-mutation-50789https://curecurrent.com/trials/the-effects-of-two-different-ventilation-strategies-on-lung-ventilation-an-ultrasonographic-evaluation-50790https://curecurrent.com/trials/lung-cancer-screening-by-low-dose-ct-scan-in-a-french-department-dep-kp80-50791https://curecurrent.com/trials/the-symptom-experience-study-in-persons-with-non-small-cell-lung-cancer-50792https://curecurrent.com/trials/probiotics-combined-with-chemotherapy-for-patients-with-advanced-nsclc-50793https://curecurrent.com/trials/functional-image-and-molecular-markers-to-predict-treatment-outcomes-in-lung-cancer-50794https://curecurrent.com/trials/liquid-biopsy-as-a-tool-to-evaluate-resistance-to-first-and-third-azd9291-egfr-tkis-in-egfr-mutant-nsclc-50795https://curecurrent.com/trials/chest-wall-motion-analysis-in-disease-50796https://curecurrent.com/trials/frequency-of-egfr-and-kras-mutations-and-clinical-prognostic-correlation-in-brazilian-lung-cancer-patients-50797https://curecurrent.com/trials/ldk378-in-adult-chinese-patients-with-alk-rearranged-alk-positive-advanced-non-small-cell-lung-cancer-nsclc-previously-t-50798https://curecurrent.com/trials/mitochondria-targeted-system-therapy-combined-with-radiofrequency-ablation-for-early-stage-non-small-cell-lung-cancer-50799https://curecurrent.com/trials/clinical-trial-of-the-efficacy-and-safety-of-ac0010-in-the-treatment-of-egfr-t790m-patients-with-advanded-nsclc-50800https://curecurrent.com/trials/high-dose-icotinib-with-sequential-srs-for-nsclc-patients-harboring-egfr-mutation-with-brain-metastases-50801https://curecurrent.com/trials/side-effects-of-anti-pd-l-1-and-anti-ctla-a4-in-the-non-small-cells-lung-cancer-50802https://curecurrent.com/trials/clinical-and-molecular-staging-of-lung-cancer-stages-i-and-iip-50803https://curecurrent.com/trials/a-study-of-atezolizumab-compared-with-gemcitabine-plus-cisplatin-or-carboplatin-for-pd-l1-selected-participants-with-sta-50804https://curecurrent.com/trials/nitroglycerin-in-non-small-cell-lung-cancer-50805https://curecurrent.com/trials/lux-lung-8-a-phase-iii-trial-of-afatinib-bibw-2992-versus-erlotinib-for-the-treatment-of-squamous-cell-lung-cancer-after-50806https://curecurrent.com/trials/epidermal-growth-factor-receptor-mutations-in-the-blood-of-patients-with-advanced-non-small-cell-lung-cancer-50807https://curecurrent.com/trials/exercise-capacity-and-physical-activity-levels-in-newly-diagnosed-hematologic-malignant-patients-50808https://curecurrent.com/trials/chloroquine-as-an-anti-autophagy-drug-in-stage-iv-small-cell-lung-cancer-sclc-patients-50809https://curecurrent.com/trials/the-tracking-molecular-evolution-for-nsclc-t-menc-study-50810https://curecurrent.com/trials/donor-lymphocyte-infusion-after-stem-cell-transplant-in-treating-patients-with-haematological-cancers-50811https://curecurrent.com/trials/fitness-activity-and-lung-cancer-study-50812https://curecurrent.com/trials/a-phase-iii-clinical-trial-of-fruquintinib-in-patients-with-advanced-non-small-cell-lung-cancer-50813https://curecurrent.com/trials/maximal-exercise-capacity-and-extra-pulmonary-characteristics-in-patients-with-lung-cancer-with-complete-remission-50814https://curecurrent.com/trials/study-of-weekly-paclitaxel-carboplatin-and-irinotecan-to-treat-lung-cancer-50815https://curecurrent.com/trials/a-trial-comparing-approaches-to-shared-decision-making-skills-training-for-clinicians-50816https://curecurrent.com/trials/a-pilot-study-of-mpdl3280a-and-higrt-in-metastatic-nsclc-50817https://curecurrent.com/trials/a-phase-1b-study-of-pegylated-recombinant-human-hyaluronidase-pegph20-combined-with-docetaxel-in-subjects-with-recurrent-50818https://curecurrent.com/trials/pet-quantitative-assessments-of-solid-tumor-response-to-immune-checkpoint-blockade-therapy-50819https://curecurrent.com/trials/a-comparative-study-of-pf-06439535-plus-paclitaxel-carboplatin-and-bevacizumab-plus-paclitaxel-carboplatin-patients-with-50820https://curecurrent.com/trials/folic-acid-tubulysin-conjugate-ec1456-in-patients-with-advanced-solid-tumors-50821https://curecurrent.com/trials/concurrent-proton-and-chemotherapy-in-locally-advanced-stage-iiia-b-non-small-cell-lung-cancer-nsclc-50822https://curecurrent.com/trials/a-study-of-ly2584702-with-erlotinib-or-everolimus-in-participants-with-solid-tumors-50823https://curecurrent.com/trials/azacitidine-and-entinostat-in-treating-patients-with-stage-i-non-small-cell-lung-cancer-that-has-been-removed-by-surgery-50824https://curecurrent.com/trials/retrospective-analysis-of-the-expression-of-the-neurotensin-receptor-by-metastatic-lung-adenocarcinomas-50825https://curecurrent.com/trials/efficacy-and-safety-of-momelotinib-combined-with-trametinib-in-adults-with-metastatic-kras-mutated-non-small-cell-lung-c-50826https://curecurrent.com/trials/photodynamic-therapy-for-the-prevention-of-lung-cancer-50827https://curecurrent.com/trials/erlotinib-and-momelotinib-for-the-treatment-of-epidermal-growth-factor-receptor-egfr-mutated-egfr-tyrosine-kinase-inhibi-50828https://curecurrent.com/trials/phase-ii-study-of-itraconazole-and-pemetrexed-in-patients-with-previously-treated-non-squamous-nsclc-50829https://curecurrent.com/trials/study-of-coti-2-as-monotherapy-or-combination-therapy-for-the-treatment-of-malignancies-50830https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-sh-1028-in-locally-advanced-or-metastatic-nsclc-50831https://curecurrent.com/trials/therapeutic-strategies-in-patients-with-non-squamous-non-small-cell-lung-cancer-with-brain-metastases-50832https://curecurrent.com/trials/biomarker-discovery-and-validation-in-lung-cancer-50833https://curecurrent.com/trials/phase-i-ii-study-to-evaluate-the-efficacy-and-safety-of-a-combination-chemotherapy-50834https://curecurrent.com/trials/preliminary-evaluation-of-safety-and-efficacy-by-14c-ac0010-trail-and-subsequent-ac0010-treatment-50835https://curecurrent.com/trials/prospective-randomized-trial-comparing-the-effectiveness-of-continuous-paravertebral-infusion-of-local-anesthetics-versu-50836https://curecurrent.com/trials/monitoring-the-changes-of-tumor-related-biomarkers-before-and-after-pulmonary-nodule-biopsy-50837https://curecurrent.com/trials/nutritional-route-in-esophageal-resection-trial-ii-50838https://curecurrent.com/trials/anlotinib-hydrochloride-combined-with-egfr-tkis-in-advanced-non-small-cell-lung-cancer-50839https://curecurrent.com/trials/a-prospective-multi-center-evaluation-of-a-powered-vascular-stapler-in-video-assisted-thoracoscopic-lobectomies-50840https://curecurrent.com/trials/efficacy-of-epidermal-growth-factor-receptor-tyrosine-kinase-inhibitor-combined-with-early-stereotactic-body-radiation-t-50841https://curecurrent.com/trials/temozolomide-combine-with-intensity-modulated-radiation-therapy-with-simultaneous-integrated-boost-for-non-small-cell-lu-50842https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-sh-1028-in-patients-with-advanced-nsclc-50843https://curecurrent.com/trials/bioinformation-therapy-for-lung-cancer-50844https://curecurrent.com/trials/evaluation-of-tolerability-and-safety-of-allergovac-poliplus-in-polysensitized-patients-with-rhinitis-or-allergic-rhinoc-50845https://curecurrent.com/trials/temsirolimus-and-bevacizumab-in-treating-patients-with-advanced-endometrial-ovarian-liver-carcinoid-or-islet-cell-cancer-50846https://curecurrent.com/trials/the-predictive-role-of-programmed-death-ligand-1-pd-l1-and-neutrophil-to-lymphocyte-ratio-nlr-in-non-small-cell-lung-can-50847https://curecurrent.com/trials/study-of-proteins-in-tumor-samples-from-patients-with-non-small-cell-lung-cancer-50848https://curecurrent.com/trials/biomarkers-of-angiogenesis-and-disease-in-patients-with-unresectable-malignant-mesothelioma-treated-on-clinical-trial-ca-50849https://curecurrent.com/trials/prospective-study-to-evaluate-mapleson-circuit-with-monitored-anesthesia-care-during-endobronchial-ultrasound-ebus-bronc-50850https://curecurrent.com/trials/non-invasive-ctdna-methylation-detection-for-lung-nodule-patients-50851https://curecurrent.com/trials/study-to-evaluate-safety-and-efficacy-of-oral-mp1032-in-psoriasis-patients-50852https://curecurrent.com/trials/the-efficacy-and-drug-resistance-molecular-biology-of-apatinib-combined-with-egfr-tk1-treated-for-advanced-slow-progress-50853https://curecurrent.com/trials/cancer-panel-from-blood-of-lung-cancer-patients-50854https://curecurrent.com/trials/the-real-word-study-of-albumin-binding-taxol-for-lung-cancer-treatment-50855https://curecurrent.com/trials/grn1005-in-non-small-cell-lung-cancer-nsclc-patients-with-brain-metastases-grabm-l-50856https://curecurrent.com/trials/molecular-profiling-in-small-cell-lung-cancer-50857https://curecurrent.com/trials/an-explorative-study-of-afatinib-in-the-treatment-of-advanced-cancer-carrying-an-egfr-a-her2-or-a-her3-mutation-50858https://curecurrent.com/trials/a-study-of-famitinib-plus-docetaxel-in-patients-with-advanced-non-squamous-and-non-small-cell-lung-cancer-nsclc-50859https://curecurrent.com/trials/a-fish-oil-supplement-to-maintain-body-weight-in-patients-with-disease-related-weight-loss-50860https://curecurrent.com/trials/shr1020-plus-docetaxel-as-compared-to-placebo-plus-docetaxel-in-2nd-line-non-squamous-non-small-cell-lung-cancer-50861https://curecurrent.com/trials/a-comprehensive-smoking-cessation-intervention-duration-radiation-for-upper-aerodigestive-cancers-50862https://curecurrent.com/trials/ny-eso-1-tcr-taest16001-for-patients-with-advanced-nsclc-50863https://curecurrent.com/trials/docetaxel-and-cisplatin-in-treating-patients-with-stage-i-stage-ii-or-stage-iii-non-small-cell-lung-cancer-that-has-been-50864https://curecurrent.com/trials/retrospective-epidemiological-study-of-lung-cancer-with-low-dose-multislice-computed-tomography-50865https://curecurrent.com/trials/efficacy-and-safety-of-sct200-in-patients-with-advanced-squamous-non-small-cell-lung-cancer-50866https://curecurrent.com/trials/clinical-trial-to-evaluate-the-safety-and-effects-of-ethnicity-and-food-on-pharmacokinetics-of-yh25448-50867https://curecurrent.com/trials/study-of-ngr-htnf-as-single-agent-in-patients-affected-by-advanced-or-metastatic-malignant-pleural-mesothelioma-50868https://curecurrent.com/trials/stereotactic-body-radiation-therapy-in-treating-patients-with-inoperable-stage-i-or-stage-ii-non-small-cell-lung-cancer-50869https://curecurrent.com/trials/trial-of-ruxolitinib-and-erlotinib-in-patients-with-egfr-mutant-lung-adenocarcinoma-with-acquired-resistance-to-erlotini-50870https://curecurrent.com/trials/shr-1210-combined-with-epirubicin-in-the-treatment-of-extensive-disease-small-cell-lung-cancer-50871https://curecurrent.com/trials/zoledronic-acid-combined-radiotherapy-for-bone-metastasis-of-non-small-cell-lung-cancer-50872https://curecurrent.com/trials/preoperative-and-postoperative-ctdna-comparison-in-early-stage-lung-cancer-50873https://curecurrent.com/trials/phase-ii-study-of-ngr-htnf-versus-placebo-as-maintenance-treatment-in-patients-with-advanced-mpm-50874https://curecurrent.com/trials/efficacy-and-safety-study-of-afatinib-to-treat-lung-cancer-patients-50875https://curecurrent.com/trials/human-mesenchymal-stem-cells-for-moderate-and-severe-bronchopulmonary-dysplasia-50876https://curecurrent.com/trials/effect-of-optimal-positive-end-expiratory-pressure-on-oxygenation-and-intrapulmonary-shunt-during-one-lung-ventilation-50877https://curecurrent.com/trials/isotoxic-accelerated-radiotherapy-in-locally-advanced-non-small-cell-lung-cancer-the-phase-i-ii-i-start-trial-50878https://curecurrent.com/trials/proton-radiotherapy-for-patients-with-non-small-cell-lung-cancer-nsclc-50879https://curecurrent.com/trials/electromagnetic-navigation-versus-ct-guided-ttna-in-the-diagnosis-of-early-peripheral-lung-cancer-50880https://curecurrent.com/trials/18f-hx4-pet-ct-imaging-for-detection-of-hypoxia-50881https://curecurrent.com/trials/betadine-pleurodesis-via-tunneled-pleural-catheters-50882https://curecurrent.com/trials/a-study-of-ldk378-in-patients-with-non-small-cell-lung-cancer-harboring-ros1-rearrangement-50883https://curecurrent.com/trials/sorafenib-and-high-dose-carboplatin-paclitaxel-and-external-beam-radiation-therapy-in-treating-patients-with-stage-iii-n-50884https://curecurrent.com/trials/vitamin-c-and-tyrosine-kinase-inhibitor-in-lung-cancer-patients-with-epidermal-growth-factor-receptor-mutations-50885https://curecurrent.com/trials/docetaxel-combined-with-carboplatin-plus-anlotinib-as-first-line-treatment-in-nsclc-50886https://curecurrent.com/trials/18f-fluorodeoxyglucose-18f-fdg-positron-emission-tomography-in-oncology-50887https://curecurrent.com/trials/a-study-of-paclitaxel-carboplatin-with-or-without-olaratumab-imc-3g3-in-previously-untreated-locally-advanced-or-metasta-50888https://curecurrent.com/trials/clinicopathological-features-of-nsclc-patients-associated-with-the-chromosome-2p-eml4-alk-50889https://curecurrent.com/trials/study-of-dacomitinib-pf-00299804-in-advanced-nsclc-patients-post-chemo-or-select-first-line-to-evaluate-prophylactic-int-50890https://curecurrent.com/trials/early-diagnosis-of-small-pulmonary-nodules-by-multi-omics-sequencing-50891https://curecurrent.com/trials/spanish-lung-liquid-vs-invasive-biopsy-program-sllip-50892https://curecurrent.com/trials/dacomitinib-pf-00299804-as-a-single-oral-agent-in-selected-patients-with-adenocarcinoma-of-the-lung-50893https://curecurrent.com/trials/study-of-tarceva-and-targretin-oral-capsules-in-patients-with-advanced-lung-cancer-50894https://curecurrent.com/trials/a-study-of-atezolizumab-in-participants-with-programmed-death-ligand-1-pd-l1-positive-locally-advanced-or-metastatic-non-50895https://curecurrent.com/trials/study-of-tarceva-and-targretin-in-stage-i-ii-lung-cancer-50896https://curecurrent.com/trials/rshf-in-colorectal-cancer-50897https://curecurrent.com/trials/ngs-genome-analysis-in-personalisation-of-lung-cancer-treatment-50898https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-sct510-in-the-treatment-of-non-small-cell-lung-cancer-50899https://curecurrent.com/trials/pharmacogenetics-in-non-small-cell-lung-cancer-50900https://curecurrent.com/trials/evaluating-an-anchored-transponder-in-lung-cancer-patients-receiving-radiation-therapy-50901https://curecurrent.com/trials/pilot-study-of-preoperative-tarceva-erlotinib-for-stages-i-ii-non-small-cell-lung-cancer-50902https://curecurrent.com/trials/a-study-of-ly2940680-in-small-cell-lung-cancer-50903https://curecurrent.com/trials/the-correlation-of-pd-l1-expression-in-non-small-lung-cancer-tissue-and-peripheral-blood-t-cell-and-serum-50904https://curecurrent.com/trials/a-randomized-study-to-compare-the-efficacy-and-safety-of-belotecan-and-topotecan-as-monotherapy-for-sensitive-relapsed-s-50905https://curecurrent.com/trials/phase-2-study-of-alisertib-mln8237-in-combination-with-paclitaxel-versus-placebo-in-combination-with-paclitaxel-as-secon-50906https://curecurrent.com/trials/aggressive-thoracic-radiotherapy-for-stage-non-small-cell-lung-cancer-50907https://curecurrent.com/trials/study-evaluating-the-safety-of-rovalpituzumab-tesirine-for-third-line-and-later-treatment-of-subjects-with-relapsed-or-r-50908https://curecurrent.com/trials/a-phase-3-multi-site-randomized-double-blind-placebo-controlled-study-of-the-efficacy-and-safety-comparing-cp-690-550-an-50909https://curecurrent.com/trials/a-study-to-evaluate-the-effects-and-safety-of-treatment-treatment-withdrawal-followed-by-re-treatment-with-cp-690-550-in-50910https://curecurrent.com/trials/high-flow-nasal-cannula-oxygen-versus-conventional-oxygen-therapy-after-pulmonary-lobectomy-50911https://curecurrent.com/trials/concurrent-egfr-tkis-and-thoracic-radiation-therapy-in-active-egfr-mutation-for-1st-line-treatment-of-stage-iv-nsclc-50912https://curecurrent.com/trials/efficacy-and-safety-of-anlotinib-as-maintenance-treatment-after-first-line-chemotherapy-in-sclc-50913https://curecurrent.com/trials/mcmaster-catheterization-for-thoracoscopic-surgery-study-50914https://curecurrent.com/trials/a-novel-erythropoiesis-stimulating-protein-nesp-darbopoetin-alfa-for-the-treatment-of-anemia-in-lung-cancer-patients-rec-50915https://curecurrent.com/trials/does-intense-regimented-surveillance-improve-the-rates-of-therapeutic-re-intervention-after-lung-cancer-surgery-50916https://curecurrent.com/trials/videothoracoscopic-vats-vs-robotic-approach-for-lobectomy-or-anatomical-segmentectomy-50917https://curecurrent.com/trials/study-of-anlotinib-as-the-maintenance-therapy-for-extensive-stage-small-cell-lung-cancer-50918https://curecurrent.com/trials/application-of-3d-printing-technique-in-small-pulmonary-nodule-localization-50919https://curecurrent.com/trials/study-of-anlotinib-combined-with-pemetrexed-in-patients-with-advanced-nonsquamous-nsclc-50920https://curecurrent.com/trials/study-of-metformin-plus-paclitaxel-carboplatin-bevacizumab-in-patients-with-adenocarcinoma-50921https://curecurrent.com/trials/autologous-tcm-cells-immunotherapy-in-patients-with-non-small-cell-lung-cancer-nsclc-50922https://curecurrent.com/trials/peg-rhg-csf-in-elderly-patients-with-small-cell-lung-cancer-receiving-chemotherapy-50923https://curecurrent.com/trials/afatinib-as-second-line-therapy-for-lung-cancer-with-epidermal-growth-factor-receptor-egfr-mutation-50924https://curecurrent.com/trials/careseng-1370-for-chemotherapy-induced-myelosuppression-50925https://curecurrent.com/trials/a-study-of-prexasertib-ly2606368-in-combination-with-ralimetinib-in-participants-with-advanced-or-metastatic-cancer-50926https://curecurrent.com/trials/a-study-of-induction-and-maintenance-treatment-of-advanced-non-squamous-non-small-cell-lung-cancer-50927https://curecurrent.com/trials/bibw-2992-afatinib-vs-gemcitabine-cisplatin-in-1st-line-non-small-cell-lung-cancer-nsclc-50928https://curecurrent.com/trials/spect-ct-in-measuring-lung-function-in-patients-with-cancer-undergoing-radiation-therapy-50929https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-50930https://curecurrent.com/trials/nsclc-heterogeneity-in-early-stage-patients-and-prediction-of-relapse-using-a-personalized-liquid-biopsy-50931https://curecurrent.com/trials/erlotinib-in-patients-with-resected-early-stage-nsclc-with-confirmed-mutations-in-the-egfr-50932https://curecurrent.com/trials/sgi-110-plus-durvalumab-tremelimumab-in-sclc-50933https://curecurrent.com/trials/phase-ii-safety-and-tolerability-trial-with-nab-paclitaxel-plus-carboplatin-followed-by-nab-paclitaxel-for-first-line-tr-50934https://curecurrent.com/trials/anlotinib-plus-sintilimab-for-nsclc-patients-with-first-generation-egfr-tkis-drug-resistance-along-with-t790m-negative-50935https://curecurrent.com/trials/erlotinib-paclitaxel-and-carboplatin-in-treating-patients-with-stage-iii-stage-iv-or-recurrent-non-small-cell-lung-cance-50936https://curecurrent.com/trials/docetaxel-and-erlotinib-in-treating-patients-with-advanced-non-small-cell-lung-cancer-or-other-solid-tumors-50937https://curecurrent.com/trials/lume-lung-1-bibf-1120-plus-docetaxel-as-compared-to-placebo-plus-docetaxel-in-2nd-line-non-small-cell-lung-cancer-50938https://curecurrent.com/trials/bavituximab-plus-carbo-and-pemetrexed-in-chemo-naive-stage-iv-non-squamous-non-small-cell-lung-cancer-nsclc-subjects-50939https://curecurrent.com/trials/localization-for-deep-lung-nodules-microcoil-versus-contrast-injection-50940https://curecurrent.com/trials/a-phase-ii-study-of-neo-adjuvant-gemcitabine-cisplatin-and-bevacizumab-in-stage-iiia-n2-non-squamous-cell-non-small-cell-50941https://curecurrent.com/trials/safety-and-efficacy-of-vitamin-c-infusion-in-combination-with-local-meht-to-treat-non-small-cell-lung-cancer-50942https://curecurrent.com/trials/a-study-of-anlotinib-in-combination-with-docetaxel-versus-docetaxel-alone-in-participants-with-advanced-nsclc-50943https://curecurrent.com/trials/icotinib-combined-with-radiation-therapy-for-nsclc-patients-with-brain-metastases-and-egfr-mutation-50944https://curecurrent.com/trials/azd-2811-monotherapy-in-relapsed-small-cell-lung-cancer-patients-sukses-n3-50945https://curecurrent.com/trials/anlotinib-combined-with-docetaxel-for-advanced-non-squamous-non-small-cell-lung-cancer-50946https://curecurrent.com/trials/phase-ib-iia-studies-of-chlorogenic-acid-for-injection-for-safety-and-efficacy-of-advanced-lung-cancer-50947https://curecurrent.com/trials/perfusion-ct-imaging-in-lung-cancer-with-sbrt-50948https://curecurrent.com/trials/changes-in-circulating-tumor-specific-dna-in-patients-with-non-metastatic-non-small-cell-lung-cancer-50949https://curecurrent.com/trials/nlcr-in-prediction-of-the-grade-of-lung-tumor-50950https://curecurrent.com/trials/icotinib-as-neoadjuvant-therapy-in-egfr-mutant-stage-a-n2-non-small-cell-lung-cancer-50951https://curecurrent.com/trials/proton-beam-re-irradiation-in-thoracic-cancers-50952https://curecurrent.com/trials/a-study-of-the-safety-tolerability-and-effects-of-cobimetinib-and-gdc-0994-in-patients-with-locally-advanced-or-metastat-50953https://curecurrent.com/trials/effect-of-osimertinib-in-ethnic-chinese-with-egfr-and-t790m-mutated-nsclc-50954https://curecurrent.com/trials/feasibility-of-a-creative-writing-intervention-in-an-advanced-cancer-population-a-single-arm-consecutive-cohort-study-50955https://curecurrent.com/trials/using-a-patient-centered-mhealth-intervention-to-improve-adherence-to-oral-anticancer-medications-50956https://curecurrent.com/trials/effect-of-yong-chong-cao-capsule-on-outcomes-in-patients-with-mild-to-severe-copd-50957https://curecurrent.com/trials/epidermal-growth-factor-receptor-egfr-t790m-mutation-testing-practices-in-hong-kong-50958https://curecurrent.com/trials/lung-protective-ventilation-during-robotic-assisted-prostatectomy-50959https://curecurrent.com/trials/safety-study-of-cb-5945-for-the-treatment-of-opioid-induced-constipation-50960https://curecurrent.com/trials/the-efficacy-and-safety-study-of-cb-5945-for-the-treatment-of-opioid-induced-constipation-50961https://curecurrent.com/trials/efficacy-and-safety-study-of-cb-5945-for-the-treatment-of-opioid-induced-constipation-50962https://curecurrent.com/trials/randomized-study-of-maintenance-therapy-with-mgn1703-in-patients-with-sclc-50963https://curecurrent.com/trials/sorafenib-and-thoracic-radiation-for-patients-with-non-small-cell-lung-cancer-50964https://curecurrent.com/trials/efficacy-and-safety-study-of-cb-5945-for-the-treatment-of-opioid-induced-constipation-50965https://curecurrent.com/trials/expanded-access-study-of-afatinib-in-treatment-naive-or-chemotherapy-pre-treated-patients-with-non-small-cell-lung-cance-50966https://curecurrent.com/trials/nivolumab-in-the-real-world-analysis-of-the-expanded-use-in-spanish-patient-50967https://curecurrent.com/trials/radiation-therapy-xrt-and-zd6474-in-non-small-cell-lung-cancer-nsclc-50968https://curecurrent.com/trials/circulating-tumor-dna-longitudinal-monitoring-in-stage-iii-iv-lung-cancer-patients-50969https://curecurrent.com/trials/low-dose-daily-erlotinib-in-combination-with-high-dose-twice-weekly-erlotinib-in-patients-with-egfr-mutant-lung-cancer-50970https://curecurrent.com/trials/temozolomide-in-patients-affected-by-relapsed-sensitive-or-refractory-small-cell-lung-cancer-with-mgmt-methylation-50971https://curecurrent.com/trials/disease-characteristics-treatment-patterns-and-clinical-outcomes-in-patients-with-newly-diagnosed-unresectable-stage-iii-50972https://curecurrent.com/trials/study-of-patient-preference-for-oral-or-intravenous-vinorelbine-in-the-treatment-of-advanced-nsclc-50973https://curecurrent.com/trials/prevention-of-post-operative-pneumonia-popp-50974https://curecurrent.com/trials/ofatumumab-vs-physician-s-choice-in-subjects-with-bulky-fludarabine-refractory-chronic-lymphocytic-leukemia-50975https://curecurrent.com/trials/anlotinib-combined-with-docetaxel-for-advanced-non-small-cell-lung-cancer-alter-l034-50976https://curecurrent.com/trials/avastin-and-tarceva-for-locally-advanced-or-metastatic-non-squamous-non-small-cell-lung-cancer-50977https://curecurrent.com/trials/anlotinib-in-treatment-of-recurrent-small-cell-lung-cancer-50978https://curecurrent.com/trials/natrecor-in-pulmonary-hypertension-50979https://curecurrent.com/trials/narrow-band-imaging-nbi-a-novel-imaging-modality-in-minimally-invasive-50980https://curecurrent.com/trials/bevacizumab-in-the-treatment-of-malignant-pleural-effusions-of-non-squamous-non-small-cell-lung-cancer-50981https://curecurrent.com/trials/thoracoscopic-lung-cancer-staging-with-the-use-of-intraoperative-ultrasound-50982https://curecurrent.com/trials/anlotinib-hydrochloride-as-second-line-therapy-in-elderly-patients-with-egfr-wild-type-lung-adenocarcinoma-50983https://curecurrent.com/trials/a-study-of-alectinib-ro5424802-in-participants-with-non-small-cell-lung-cancer-who-have-anaplastic-lymphoma-kinase-alk-m-50984https://curecurrent.com/trials/simultaneous-coronary-artery-evaluation-and-lung-cancer-ct-screening-50985https://curecurrent.com/trials/engagement-of-patients-with-advanced-cancer-50986https://curecurrent.com/trials/isotoxic-intensity-modulated-radiotherapy-imrt-in-stage-iii-non-small-cell-lung-cancer-nsclc-a-feasibility-study-50987https://curecurrent.com/trials/bortezomib-and-pemetrexed-disodium-in-treating-patients-with-advanced-non-small-cell-lung-cancer-or-other-solid-tumors-50988https://curecurrent.com/trials/a-study-of-erlotinib-in-participants-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-with-epidermal-growt-50989https://curecurrent.com/trials/sunitinib-in-never-smokers-with-lung-adenocarcinoma-50990https://curecurrent.com/trials/detection-of-heterogeneity-in-central-lung-cancer-ebus-tbna-and-ctdna-analysis-vs-endobronchial-forceps-biopsy-50991https://curecurrent.com/trials/phase-ii-study-of-sch66336-a-farnesyltransferase-inhibitor-in-chronic-myelogenous-leukemia-cml-50992https://curecurrent.com/trials/anticoagulation-length-in-cancer-associated-thrombosis-50993https://curecurrent.com/trials/paclitaxel-detection-in-nsclc-treated-with-tc-regimen-50994https://curecurrent.com/trials/progression-of-untreated-pulmonary-ground-glass-opacity-50995https://curecurrent.com/trials/a-study-of-patient-reported-outcomes-in-patients-with-lung-or-esophageal-cancer-50996https://curecurrent.com/trials/cisplatin-and-gemcitabine-plus-trastuzumab-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-50997https://curecurrent.com/trials/parp-inhibitor-in-advanced-non-small-cell-lung-cancer-pin-50998https://curecurrent.com/trials/4-dimensional-ct-derived-ventilation-versus-spect-aerosol-ventilation-in-patients-with-thoracic-malignancies-50999https://curecurrent.com/trials/efficacy-and-safety-of-apatinib-as-third-line-therapy-for-primary-pulmonary-lymphoepithelioid-carcinoma-51000